Peak oxygen uptake and habitual exercise as a basis for primary prevention by Nes, Bjarne Martens
ISBN 978-82-471-xxxx-x (printed version)
ISBN 978-82-471-xxxx-x (electronic version)
ISSN 1503-8181
Doctoral theses at NTNU, 2010:XX
Fornavn Etternavn
Doctoral theses at NTNU, 2010:23
Fornavn Etternavn
NTNU
Norwegian University of Science and Technology
Thesis for the degree of philosophiae doctor
Faculty of Engineering Science and Technology
Department of Marine Technology
Tittel på avhandlingen
Undertittel på avhandlingen
3 368
Bjarne Martens Nes
Peak oxygen uptake and  
habitual exercise as a basis 
for primary prevention
ISBN 978-82-4714888 4
 4889 1 
D
octoral theses at N
TN
U
, 2013:368
B
jarne M
artens N
es
N
TN
U
N
or
w
eg
ia
n 
U
ni
ve
rs
ity
 o
f S
ci
en
ce
 a
nd
 T
ec
hn
ol
og
y
Th
es
is
 fo
r 
th
e 
de
gr
ee
 o
f P
hi
lo
so
ph
ia
e 
D
oc
to
r
 F
ac
ul
ty
 o
f M
ed
ic
in
e
D
ep
ar
tm
en
t o
f C
ir
cu
la
tio
n 
an
d 
M
ed
ic
al
 Im
ag
in
g
Thesis for the degree of philosophiae doctor
Trondheim, xxxx 2010
Norwegian University of Science and Technology
Faculty of Engineering Science and Technology
Department of Marine Technology
Fornavn Etternavn
Tittel på avhandlingen
Undertittel på avhandlingen
Bjarne Mart ns Nes
Peak oxygen uptake and 
habitual exercise as a basis 
for primary prevention
P D t
i  December 2013
l
Medicine
Circulation and Medical Imaging
NTNU
Norwegian University of Science and Technology
©
ISSN 1503-8181
IMT Report 2010-xx
Doctoral Theses at NTNU, 2010:xx
Printed by Skipnes Kommunikasjon as
Thesis for the degree of philosophiae doctor
Faculty of Engineering Science and Technology
Department of Marine Technology
Fornavn Etternavn
ISBN 82-471-xxxx-x (printed ver.)
ISBN 82-471-xxxx-x (electronic ver.)
l
P  Doctor
Medicine
Circulation and Medical Imaging
Bjarne Mart ns Nes
978-82 4714888-4 (print d version)
978-82 471-4889-1 (electronic version)
theses at NTNU, 2013:368
i s Kommunikasjon as
   
 
I 
 
SAMANDRAG 
Maksimalt oksygenopptak (VO2peak) er rekna som ein av dei viktigaste prognostiske 
markørane for framtidig hjarte-/karsjukdom og tidleg død. Ettersom direkte måling av VO2peak 
er tidkrevjande og kostbart har implementeringa i førebyggjande helsearbeid og klinisk 
praksis vore begrensa. Både VO2peak og ei rekkje andre sentrale helseparameter, kan betrast 
ved ei viss mengd fysisk aktivitet i kvardagen, og dagens globale anbefalingar er at alle 
vaksne bør utføre minst 150 minutt med moderat intensitet eller minst 75 minutt med høg 
intensitet per veke. Utforminga av anbefalingane inneber at det totale energiforbruket, og 
dermed helsegevinstane, kan oppnås ved ulike tilnærmingar der kortare varigheit kan 
kompenserast med høgare intensitet og vice versa. I dette prosjektet nytta me data på direkte 
målt VO2peak frå 4631 deltakarar i den siste Helseundersøkelsen i Nord-Trøndelag (HUNT 3, 
2006-08) til først å utvikle ein prediksjonsmodell for å kunne estimere VO2peak og vidare 
undersøke om denne modellen kunne predikere framtidig hjerte-/kardødeligheit og død 
uansett årsak i ein stor befolkning. Me såg vidare på korleis ulike tilnærmingar til dagens 
anbefalingar for fysisk aktivitet var assosiert med direkte målt VO2peak i utvalet frå HUNT. 
Hovedfunna i avhandlinga er at VO2peak kan estimerast relativt nøyaktig ved ein 
regresjonsmodell med lett tilgjengelige variablar som alder, kroppssamansetning, fysisk 
aktivitetsnivå og kvilepuls og at modellen kan nyttast til å kategorisere personar med låg eller 
høg direkte målt VO2peak. Denne modellen vart nytta til å estimere VO2peak i eit stort utval 
friske deltakarar frå HUNT 1 (1984-86) som vart fulgt fram til registrert dødsdato eller slutten 
av 2010. For kvar 3,5 mL∙kg-1∙min-1 høgare estimert VO2peak var risikoen for død av hjarte-
/karsjukdom 21 % lågare for personar av begge kjønn som var under 60 år ved undersøkelsen, 
medan risikoen uansett dødsårsak var henholdsvis 15 % og 8 % lågare for menn og kvinner. 
Vidare viser me at grupper som rapporterer fysisk aktivitetsvanar i tråd med dagens 
anbefalingar, anten ved moderat relativ intensitet over lengre tid eller høg intensitet over 
kortare tid, i gjennomsnitt hadde tilfredsstillande høg og tilnærma lik VO2peak. Samtidig viser 
me at eit relativt begrensa antal personar som rapporterte ein tidsbruk under minimum 
anbefaling, men med svært høg relativ intensitet, også hadde tilsvarande høg VO2peak. Også 
når tidsbruken eller det samla energiforbruket var konstant fann me at dei som rapporterte høg 
intensitet hadde høgare VO2peak enn dei som rapporterte låg eller moderate intensitet. 
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SUMMARY 
Directly measured peak oxygen uptake (VO2peak) is established as an important prognostic 
marker of cardiovascular disease and premature mortality, but is rarely evaluated for 
prevention purposes or in primary care settings due to costly and time-consuming procedures. 
Both VO2peak and several other health parameters can, however, be improved and maintained 
by regular exercise, and today`s recommendations suggest that all adults should do at least 
150 minutes of moderate intensity or 75 minutes or vigorous intensity exercise per week. 
Hence, the total recommended volume or energy expenditure may be reached by strictly 
different approaches. In the current thesis, data on directly measured VO2peak in 4631 
individuals from the third wave of the Nord-Trøndelag Health Study (HUNT 3, 2006-08), 
were used to first derive a simple prediction model for VO2peak that potentially could 
supplement direct measurements in healthcare settings and for research purposes. Next, the 
clinical utility of this model was examined by its ability to predict all-cause and 
cardiovascular mortality in a large sample of healthy men and women from the HUNT 1 
(1984-86) cohort. Furthermore, we examined how different combinations of intensity and 
total time spent at habitual exercise were associated with VO2peak in apparently healthy, 
community dwelling individuals from HUNT 3. The findings in this thesis indicate that 
VO2peak can be predicted with reasonable accuracy by using easily available clinical and self-
reported variables such as age, body composition, self-reported physical activity and resting 
heart rate, and that the model can be used to correctly classify subjects in the correct tail of the 
VO2peak distribution. For each metabolic equivalent (i.e. MET, ~3.5 mL∙kg
-1∙min-1) higher 
CRF, the risk of CVD mortality was 21% lower in both men and women who were below 60 
years at baseline, while the corresponding risk of all-cause mortality was 15% and 8% lower 
in men and  women, respectively, for each MET higher CRF. Furthermore, we demonstrate 
that habitual exercise patterns of moderate intensity for a long total duration or vigorous 
intensity for a relatively short duration, adding up to the total volume as recommended by the 
health authorities, both were associated with a beneficial VO2peak –level. However, a higher 
VO2peak was observed among those reporting vigorous intensity compared to low and 
moderate intensity for a similar time spent, and energy expenditure used during exercise. 
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DEFINITIONS 
 
Cardiorespiratory fitness: 
The ability to perform large-muscle dynamic moderate-to-high intensity exercise for 
prolonged periods
1
. 
 
Exercise: 
Physical activity that is planned, structured and repetitive and has as a final or intermediate 
objective the improvement or maintenance of physical fitness
2,3
. 
 
Maximal/peak oxygen uptake (VO2max/peak): 
The highest rate at which oxygen can be taken up and utilized by the body during strenuous, 
dynamic exercise with a large muscle mass
4
. 
 
Metabolic equivalent (MET): 
METs is the ratio of the rate of energy expended during an activity to the rate of energy 
expended at rest
2
. 1 MET is the rate of energy expenditure while sitting at rest and is, by 
convention, defined as 3.5 mL∙kg-1∙min-1 5. 
 
Non-exercise model: 
A multiple regression model derived to estimate the level of cardiorespiratory fitness without 
exercise testing 
 
Physical activity: 
Any voluntary movement produced by skeletal muscles that result in energy expenditure 
above resting levels
2,3
. 
 
Physical fitness: 
A set of attributes that people have or achieve that relates to the ability to perform physical 
activity
3
. 
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  Background 
 
1 
 
BACKGROUND 
 
The past century represented a dramatic epidemiological transition in the burden of disease 
worldwide. While communicable diseases have been the leading cause of deaths for many 
decades, recent reports states that preventable, non-communicable diseases (i.e. 
cardiovascular disease, cancer, chronic pulmonary diseases and type 2 diabetes) now account 
for at least 60% of all deaths globally
6
. The majority of these diseases share a number of 
common modifiable risk factors, where the most prominent are unhealthy diet, high blood 
pressure, high cholesterol, tobacco smoking, obesity and physical inactivity
7
. The Global 
Burden of Disease Study conservatively estimated that lack of physical activity (PA) alone 
accounted for ~3.2 million deaths worldwide in 2010
7
. In comparison ~5.7 million deaths 
were attributed to smoking and ~1.4 million to child and maternal under-nutrition. Similarly 
important is that inactivity may be causally related to several other high ranked risk factors, 
and combined with an increasing prevalence worldwide, inactivity might now be regarded as 
one of the leading global health problems
8,9
. Additionally, a certain amount of regular PA is a 
prerequisite for maintaining or improving several aspects of physical fitness, and in particular 
cardiorespiratory fitness (CRF), which is suggested to be an even stronger predictor of 
morbidity and premature mortality than inactivity
10,11
.  
 
Against this backdrop, the public health attention to PA levels has evolved rapidly 
over the last 20 years. Several national governments, as well as global organizations such as 
World Health Organization (WHO) and the United Nations, have placed increased PA higher 
on the agenda and launched strategies and action plans aiming to combat the growing burden 
of inactivity related disease
12-16
. Individual patient counseling in primary care, however, are 
commonly restricted to assessment of  more traditional health indicators (commonly referred 
to as `vital signs`) such as pulse rate, blood pressure, respiratory rate and body temperature
17
. 
Established cardiovascular risk factors such as overweight, dyslipidemia, smoking and family 
history of disease have also gained recognition and are commonly evaluated collectively 
through so-called risk-score models such as the Framingham Risk Score, Q-Risk or the 
European Score prediction chart
18-20
. Physical inactivity, and in particular low CRF, has 
received less attention despite a growing body of evidence supporting its important prognostic 
utility
21-25
. However, through the Exercise is Medicine
®
 initiative, the American College of 
Sports Medicine (ACSM) in partnership with the American Medical Association, now 
encourages that measurement of PA status should be included as a vital sign at every clinical 
visit. A large healthcare system, Kaiser Permanente in California (USA), comprising more 
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than 3.4 million residents and 4000 physicians, has served as a role model and pioneered the 
inclusion of the PA vital sign
26
. At every visit, for every patient, two questions on frequency 
and duration of moderate-to-vigorous PA are used to calculate minutes per week of exercise 
which is automatically recorded in the electronic medical journals.  
 
An individuals` CRF, however, is not routinely examined in healthcare settings despite 
that CRF appears to be strongly associated with overall health status and future risk of chronic 
disease in both high-risk and apparently healthy persons
24,27-29
. Indeed, some studies suggest 
that the CRF level is a better predictor than traditional health parameters such as hypertension, 
smoking, overweight, dyslipidemia and type 2 diabetes
24,30
. Nevertheless, regular 
measurement of CRF is presently limited to prognostic evaluation in heart disease patients or 
as the cardinal performance measure in endurance athletes
31,32
.  
Physical activity and cardiorespiratory fitness as separate risk factors 
Although closely related and often used interchangeably, PA and CRF have strictly different 
meanings. PA is a behavior which is commonly quantified by the total volume performed i.e. 
by multiplying the number of bouts or sessions (frequency), the time of participation of each 
single session (duration) and the physiological effort associated with the PA (intensity), 
respectively
2
. On the other hand, CRF is a physiological attribute related to the ability to do 
strenuous exercise and is highly dependent on the upper limit of the cardiovascular system to 
supply and extract oxygen
3
. Both PA and CRF are inversely related to cardiovascular disease, 
its risk factors, and premature cardiovascular and all-cause mortality
33-37
. Some studies report 
that PA and CRF are related to these health outcomes independent of each other and it has 
also been suggested that the health-promoting effect goes through different mechanisms
38,39
. 
A meta-analysis from 2001 proposed that PA and CRF certainly have different relationships 
to cardiovascular risk
39
. While a relatively linear risk reduction was observed across strata of 
self-reported PA, a considerably greater benefit was found in the lower end of the CRF 
spectrum (until approximately the 20
th
 percentile). The finding that the greatest risk 
improvement is observed between the least fit and the next least fit groups are consistent 
among several large population based studies, although specific cut-off values associated with 
increased risk are yet to be established
28,40,41
. Nevertheless, few studies have examined the 
combined effect of PA and CRF in order to elucidate what is more important for future health 
outcomes. Recently, Lee et al. examined the combined associations and relative contributions 
of PA and CRF with all-cause mortality in ~42,000 healthy men and women from the 
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Aerobics Center Longitudinal Study (ACLS) cohort
10
. They reported that men and women 
who did not meet the recommended level of PA, but were among the 40% most fit for their 
age group, had lowered risk of premature mortality. On the contrary, those who met the 
recommended level of PA, but were among the 20% with lowest CRF, did not have 
significantly lower relative risks compared to those who were both inactive and unfit. 
Similarly, Sassen et al. reported that the relation between PA and cardiovascular risk factors 
disappeared when the level of CRF was adjusted for, while adjustment for PA volume did not 
attenuate the relationship between CRF and cardiovascular risk
42
. Moreover, high intensity 
PA was the main characteristic of PA in determining the risk factor prevalence. Consequently, 
one may propose that a low level of CRF warrants consideration as a risk factor independent 
of overall PA level. Also, it may be speculated that the association between PA and health and 
longevity are largely mediated by CRF. 
Maximal/peak oxygen uptake (VO2max/peak) 
Maximal oxygen uptake (VO2max) is recognized as the gold standard measurement of CRF
32
. 
VO2max is defined as the highest rate of oxygen uptake obtained during strenuous, dynamical 
work involving large muscle groups
3
. The oxygen uptake (VO2) is set by the Fick equation 
(VO2 = heart rate × cardiac stroke volume × arteriovenous O2-difference) and VO2max is 
therefore equal to the maximal ability of the cardiopulmonary system to supply, and skeletal 
muscles and the heart muscle cells to extract, oxygen during dynamical muscle work. The 
measurement of VO2max is generally performed by ventilatory gas analysis during an 
incremental treadmill or bicycle protocol to exhaustion
43
. In principle, the term VO2max 
implies that a maximal physiologic limit is achieved and objective criteria are suggested to 
consolidate that the rate of oxygen transport are maximized
44
. The plateau criterion implies 
that no further increase in oxygen uptake is seen despite increase in workload. As a secondary 
criterion of VO2max, the respiratory exchange ratio (RER) should generally exceed a pre-
specified level, typically ≥1.05-1.10, in order to certify that a near maximum effort is 
obtained. However, both the ability to reach a plateau, and the corresponding RER, vary 
considerably among individuals, despite maximal exercise, and in most clinical settings the 
term VO2peak seems more appropriate
44
. 
 
Lack of established reference values of VO2peak and consensus on clinically relevant 
cut-off values that defines increased risk for different populations may have limited the 
implementation of CRF measurement in healthcare settings
32
. Other reasons may be that the 
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procedure for direct measurement is time-consuming, expensive, requires extra facilities, 
trained personnel and a high degree of motivation and effort from the individual with possible 
accompanying risks. Some of these constraints have been overcome by the development of 
exercise protocols that estimates VO2peak from surrogate measures such as total treadmill time, 
heart rate at sub-maximal levels, perceived exertion or maximal watt production
45-47
. 
Although these protocols may be more cost-effective and applicable for mass testing, the 
feasibility in most time-limited healthcare settings seems questionable. Recently, a group of 
leading experts in the field, on behalf of the American Heart Association, have claimed for a 
national registry for CRF in the United States with the possibility of international expansion
32
. 
The expert group specifically emphasized the need for establishment of normative data for the 
population using directly measured VO2 by maximal exercise testing and the potential to 
derive prediction formulas for CRF from other variables in the registry.  
Non-exercise models of peak oxygen uptake 
The strong statistical association between VO2peak and certain health indicators such as age, 
PA, body composition, smoking status, resting heart rate, nutritional status and occupation 
have facilitated the development of multivariable regression models that combined explains a 
substantial proportion of the variance in VO2peak. Such prediction models, commonly referred 
to in the literature as non-exercise models, predict VO2peak reasonably well and are therefore 
suggested as surrogate measures when exercise testing is inapplicable. Already in 1973, a 
classical study by Bruce and colleagues indicated the feasibility of predicting VO2peak from 
easily obtainable variables such as sex, age, weight and physical exercise habits in 295 
healthy adults
45
. In the coming decades several studies attempted to examine the associations 
between CRF and anthropometrical or behavioral data, or a combination of both
48-50
.  
 
The first study that was deliberately designed to develop and cross-validate a non-
exercise model for assessment of VO2peak was probably that from Jackson et al in 1990
51
. 
Their cohort consisted of 2009, predominantly male (~90%), NASA employees who 
performed a graded maximal exercise test as part of their annual health examination. A 
multiple regression analysis revealed that age, sex, self-reported PA and body composition 
(BMI or percent body fat) were predictors of VO2peak. Together these variables explained 61% 
of the variance in VO2peak when BMI was included in the model and slightly more with 
percent body fat. The precision of the model was comparable or better (standard error of the 
estimate, SEE, was ~5.5 mL∙kg-1∙min-1 for the two models, respectively) than the Åstrand-
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Rhyming test, which is a well-established sub-maximal exercise tests widely used to estimate 
VO2peak. Cross-validation in a sub-sample from the same cohort and in hypertensive 
individuals and persons with a positive electrocardiogram confirmed the accuracy of the 
model. The study contained a relatively low number of females (n=150 for the validation 
sample and n=43 for the cross-validation sample), but its applicability was later confirmed by 
a validation study in 165 females 18-45 years
52
. A limitation of the study was that the non-
exercise model systematically underestimated CRF in well-trained participants with a VO2peak 
>55 mL∙kg-1∙min-1. This limitation was later confirmed by a validation study in well-trained 
college students with a mean age of 21 years
53
.  
 
In 2005, an international group of experts expanded on the work by Jackson et al. by 
deriving and cross-validating non-exercise models in three large epidemiological databases 
(total n=38,137)
54
. Similar variables as in the original study were used to develop new cohort-
specific models in a larger group of NASA employees, participants in the ACLS Study at the 
Cooper Clinic, and the Allied Dunbar National Fitness Survey (ADNFS) in the UK. The 
NASA model was the most accurate and showed the highest cross-validity when applied to 
the other cohorts. The superior model fit is likely explained by the measurement method used 
for determining CRF, since in the NASA cohort CRF was measured directly as VO2peak, 
whereas it was estimated from maximal and sub-maximal exercise testing, respectively, in 
ACLS and ADNFS. Subsequent validation studies have confirmed its validity in healthy 
elderly
55
.  
Associations between physical activity and peak oxygen uptake 
It is well established from randomized controlled trials that exercise training and VO2peak is 
causally related, and structured PA is recognized as the main method to improve VO2peak
2,56
. 
Nevertheless, most population based studies including healthy participants indicate a weak to 
moderate relationship between self-reported habitual PA and VO2peak
57
. For example, a cross-
sectional study from the Baltimore Longitudinal Study of Aging reported quite moderate 
correlations between overall self-reported PA and VO2peak in 1116 healthy individuals over a 
wide age-range (r=0.28 and r=0.27 in men and women, respectively)
57
. After adjustment for 
age Lakka et al. reported a weak correlation (r=0.11) between VO2peak and a wide range of 
conditioning PA in middle-aged men
38
. Similar associations have been reported in other 
populations with different age-ranges
58-60
. 
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The relatively weak association between PA levels and VO2peak at the population level, 
and stronger association with health outcomes for the latter, has generally been attributed to 
how PA has been measured
61
. Self-reported PA by questionnaires, the most widely used 
approach in population studies, are inherently prone to bias which threatens internal validity
62
. 
On the contrary, CRF levels can be measured directly with low measurement error and high 
reproducibility
63
. In recent years, however, objective measurement of PA by activity monitors 
has been introduced also in large-scale studies
64,65
. The correlation between objectively 
measured PA and VO2peak, however, is not very different from those obtained for self-reported 
PA with correlations generally ranging from 0.15-0.40
66-68
. Hence, the inherent bias of self-
report data does not seem to fully account for the weak association. Other influencing factors 
in the PA-VO2peak dose-response relationship are genetics, sex, age and individual fitness 
level
69,70
. The heritability of VO2peak have been estimated to be at least 50% and may hence be 
a primary contributor to the observed heterogeneity in VO2peak between subjects with similar 
exercise patterns
71,72
. Genetics have also been shown to play a major role in the observed 
responsiveness to a standardized exercise program
73,74
. Moreover, the separate domains of 
PA, including frequency, duration and intensity of activity, have seldom been taken into 
account in population studies. Talbot et al. reported markedly different associations with 
VO2peak for high-, moderate- and low-intensity activity, respectively in a heterogeneous 
population of community dwellers
57. Activities requiring vigorous absolute intensity (≥6 
metabolic equivalents, METs) were moderately associated with VO2peak (r=0.33 and 0.27 in 
men and women, respectively), while a weak association was found for moderate intensity 
(r=0.12 and 0.17 for men and women, respectively) and no association was observed for light 
intensity (r=0.08 and 0.06 for men and women, respectively). Several other observational 
studies have reported stronger associations between VO2peak and self-reported vigorous 
intensity PA, compared to moderate intensity or total volume of PA
60,75,76
. Only a handful 
population based studies, however, have examined how different intensities during 
unsupervised, freely selected exercise are associated with VO2peak at the same or a higher total 
duration or volume performed. 
Current physical activity recommendations for apparently healthy adults 
The WHO`s global PA recommendations for healthy adults is to achieve a minimum of 150 
minutes of moderate intensity PA throughout the week or at least 75 minutes of vigorous 
intensity PA per week
13
. The recommended total duration could be obtained by accumulating 
bouts of at least 10 minutes and should preferably be spread throughout the week. 
  Background 
 
7 
 
Conceptually similar recommendations were first launched in 1995, almost simultaneously as 
the first public health guidelines for PA in the U.S. were published by the ACSM and Centers 
for Disease Control and Prevention, which set the stage for a governmental report from the 
U.S. Surgeon General
16
. The primary recommendations were highly consistent across the 
different expert panels and represented a paradigm shift from an exercise for fitness approach 
to PA for health promotion. These guidelines were cornerstone publications that were soon 
adopted, with no or minor modifications, by a number of countries worldwide, including 
Norway
77
. 
 
The ACSM and the American Heart Association have extended on the primary 
recommendations and developed group-specific recommendations for physical activity for 
elderly
78,79
, heart disease patients
80
, diabetes patients and more
81
. Additionally, the ACSM 
have developed specific recommendations for the purpose of exercise prescription in primary 
care, with special emphasis on the quantity and quality of exercise needed for developing and 
maintaining CRF
2
. Basically, these recommendations coincide with the general guidelines for 
health promotion and disease prevention, but are extended to include musculoskeletal and 
neuromotor fitness.  
  
The primary recommendation before 1995 was to undertake vigorous intensity activity 
in bouts of at least 20 minutes with the aim of increasing physical fitness
82
. The highlighting 
of moderate intensity activity, such as brisk walking, was a somewhat controversial topic 
when the recommendations were first published
83
. Apparently, the new recommendations 
were based on a tentative conclusion that recommending moderate intensity activity, and 
allowing for accumulating bouts throughout the day, was the best-buy approach for promoting 
PA in an increasingly sedentary population. However, a large number of studies, although 
mostly published after the shift in recommendations, have confirmed the benefit of moderate 
intensity activity to reduce morbidity and premature mortality
37,84
. Notably, the 
recommendations can now be reached by either moderate or vigorous intensity activity, or a 
combination of both, provided a certain total volume of energy expenditure is satisfied. An 
inherent implication is that there is a 2:1 ratio between time spent at vigorous and moderate 
intensity activity with concern to health outcomes. This seems to be based on an assumption 
that it is the total amount of work that matters and that energy expenditure will be equal by 
doubling the total duration of moderate as compared to vigorous intensity activity. In this 
case, the benefits of recommending and undertaking vigorous intensity PA are solely 
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restricted to being a time efficient alternative. What has been less clear, however, is whether 
higher intensities confers benefits compared to moderate intensities for the same amount of 
energy expenditure. Although this has been proposed by small scale randomized trials
85
, most 
epidemiological studies that have proposed larger benefits of higher intensity have not taken 
into account that PA undertaken at higher intensity also confers a higher total volume of 
exercise. Moreover, some recent large-scale studies have reported risk reductions for both 
cardiovascular disease and all-cause mortality at PA volumes as low as half of that expressed 
in current recommendations
86
. The recommended amount and intensity of exercise have also 
never been validated against directly measured VO2peak at the population level.  
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AIMS AND HYPOTHESES 
 
The main aim of the current thesis was to further examine the correlates of VO2peak in a large, 
healthy population and explore the possibility of accurately estimating VO2peak without 
exercise testing. Furthermore we wanted to examine how freely selected, self-reported 
exercise patterns were associated with VO2peak in a large sample of healthy, community 
dwelling men and women. 
 
SPECIFIC AIMS 
 
Prediction of VO2peak from non-exercise variables 
 
To derive and cross-validate a simple, non-exercise based prediction model of VO2peak that 
could potentially be incorporated in healthcare settings. 
 
We hypothesized that age and a set of modifiable clinical and self-reported variables could 
explain a large proportion of the variance in VO2peak and thus be used to predict VO2peak 
without exercise testing. 
 
 
The association between self-reported exercise patterns and VO2peak 
 
To cross-sectionally examine how different combinations of intensity and total time spent at 
habitual exercise were associated with VO2peak in an apparently healthy, free-living 
population. 
 
We hypothesized that vigorous intensity of exercise was associated with higher VO2peak than 
low and moderate intensity for the same time spent and total volume performed on habitual 
exercise. 
 
 
Estimated VO2peak and long-term mortality 
 
To evaluate the predictive value of estimated VO2peak from a non-exercise model for long-
term (~24 years) mortality in men and women who were healthy at baseline. 
 
We hypothesized that estimated VO2peak at baseline were inversely associated with the risk of 
premature CVD and all-cause mortality. 
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MATERIAL AND METHODS 
The Nord-Trøndelag Health Study (HUNT) 
The Nord-Trøndelag Health Study (Norwegian spelling: “Helseundersøkelsen i Nord-
Trøndelag», abbreviated HUNT) is a longitudinal, population-based health survey in Norway. 
Nord-Trøndelag County is located in the middle of the country, covers both inland and coastal 
areas and consists of 24 smaller municipalities (Figure 2). Briefly, the county is regarded 
demographically similar to Norway as a whole, except from an education level and income 
slightly below the national average
87
. The population is stable and homogenous regarding 
ethnicity (mostly Caucasians) and socio-economic status and has a low net migration. The 
HUNT Study is regarded as one of the most comprehensive population-based health surveys 
in the world and invites all residents above 20 years of age to participate. The survey has been 
carried out at three occasions, the first in 1984-86 (HUNT 1), the second in 1995-97 (HUNT 
2) and the third in 2006-08 (HUNT 3). From the first survey in the mid-eighties, the study has 
been consecutively expanded to include a large number of sub-studies which examines 
different aspects relevant to the major public health issues of the time. The main strength of 
the HUNT Study is the wide range of information, excellent data quality, involvement of a 
whole unselected population, easy linkage to other health registries and a generally high 
participation rate. In HUNT 1 ~89% of those invited chose to participate, while the 
corresponding rates for HUNT 2 and 3 were ~69% and ~54%, respectively (Figure 1). The 
HUNT Study is collaboration between the HUNT Research Centre (at Department of Public 
Health, The Faculty of Medicine, NTNU), Nord-Trøndelag County Council and the 
Norwegian Institute of Public Health. The current thesis contains data from HUNT 1 and 
HUNT 3. 
 
  
 
 
 
 
 
 
 
 
Figure 1: Flow-chart of invited and participated adults (≥20 years) in the three HUNT surveys including the 
HUNT Fitness Study. 
 
HUNT 1 (1984-86) 
Invited: 86,404 
Participated: 77.212 
HUNT 2 (1995-97) 
Invited: 93,898 
Participated: 65,237 
HUNT 3 (2006-08) 
Invited: 93,860 
Participated: 50,807 
HUNT Fitness Study 
Invited: 12,609 
Appeared: 5,633 
Measured VO2peak: 4,631 
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Figure 2: Nord-Trøndelag County with its 24 municipalities. Courtesy: Krokstad et al. 2012. 
The HUNT Fitness Study 
The HUNT Fitness Study was a sub-study in HUNT 3 designed to obtain normal values of 
VO2peak in a healthy population. The study was carried out between June 2007 and June 2008. 
Four municipalities within the county (Stjørdal, Verdal, Levanger and Namsos) were chosen 
in advance and the VO2peak testing was performed in connection with the basic HUNT 
examination. Exclusion criteria for participation in the HUNT Fitness Study were known 
cardiovascular disease, cancer, obstructive lung disease and use of blood pressure medication. 
Further exclusions were done for blindness, pregnancy and any physical impairment 
preventing intense treadmill walking. Before exercise testing all participants also had to pass a 
brief medical interview involving the abovementioned exclusion criteria. A total of 12,609 
persons were offered participation in the HUNT Fitness Study and at study closure 4631 
individuals (2,368 women and 2,263 men, age: 19-90 years) had their VO2peak tested. At 
present, these data provides one of the largest reference materials of objectively measured 
VO2peak over a wide age range. A detailed description of the enrollment procedure and a 
participation flow-chart is presented elsewhere
88
. In addition to measurement of VO2peak the 
HUNT Fitness Study also involved measurement of endothelial function from flow-mediated 
dilatation (FMD) of the brachial artery using ultrasound technology (Vivid-I, GE Healthcare, 
USA), and apprehension of questionnaire-based information about pain and health-related 
quality of life. These data, however, were not used in the thesis.  
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Clinical measurements 
All clinical measurements were performed by trained nurses at the local HUNT examination 
facility. Height and body weight was read to the nearest centimeter (cm) and 0.5 kilogram 
(kg), respectively, using internally standardized measures (Model DS-102, Arctic Heating AS, 
Nøtterøy, Norway). Body mass index (BMI) was calculated by dividing body weight by the 
squared value of height in meters. Waist circumference (WC) was only measured in HUNT 3 
and read to the nearest centimeter using a steel band horizontally at the height of the 
umbilicus. Blood pressure was measured three times by an automatic oscillometry (Dinamap 
845XT, Critikon) and the mean of the second and third reading was used for analysis. Resting 
heart rate in HUNT 1 was measured by palpating the radial pulse over 15 seconds after at 
least four minutes of seated rest. In the case of irregular pulse or difficulties counting heart 
beats, the test was extended to 30 seconds, if necessary with a stethoscope placed over the 
heart. In The HUNT Fitness Study, the lowest heart rate was registered by 3-point 
electrocardiogram during FMD measurement with the participants lying in supine position on 
a bench for 10 minutes in a dim lit and quiet room. Blood samples were drawn from the 
participants in HUNT 3 and non-fasting glucose, triglycerides, total cholesterol and HDL 
cholesterol was analyzed in addition to some biomarkers not relevant for the present thesis.  
Peak oxygen uptake measurements 
Prior to the maximal exercise test, all participants carried out a 10 minute warm-up period. 
After a brief introduction to treadmill walking or running, preferably without hand-rail grasp, 
the speed was individually adjusted to a work-load causing slightly increased breathing and 
hart rate. Before entering the test treadmill (DK7830; DK City, Taichung, Taiwan) all 
participants were equipped with a face-mask (Hans Rudolph, Shawnee, KS) and heart rate 
monitor (Polar S610 or RS400; Polar Electro Oy, Kempele, Finland) and instructed in detail 
about test procedures. Oxygen uptake (VO2) and heart rate were then measured continuously 
during an incremental, individualized treadmill protocol until exhaustion. VO2 kinetics was 
measured directly by a portable mixing chamber gas analyzer (MetaMax II; Cortex, Leipzig, 
Germany). The initial workload was chosen from the warm-up pace, and speed and/or 
inclination was then increased whenever the participant reached an oxygen uptake that was 
stable over 30 seconds. As a prolongation of the warm-up period, and before exhaustion was 
reached, most participants had their steady-state VO2 measured during one (n=2773) or two 
(n=2543) submaximal levels. For each level, speed (km/h), inclination (%), heart rate and 
subjective level of exertion on the Borg 6-20 scale was registered in addition to VO2. A test 
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was considered maximal (VO2max) if the VO2 did not increase more than 2 mL∙kg
-1∙min-1 
despite increased workload, combined with a respiratory exchange ratio at or above 1.05. 
Since 12.6% of the participants did not reach both the VO2max criteria, the term VO2peak are 
used throughout this thesis and in the corresponding papers. An individual`s VO2peak was 
registered as the mean of the three successively highest 10 seconds VO2 registrations. A 
detailed description of the test protocol is previously published by our group
89
. The test 
equipment was calibrated with volume calibration repeated every third test and two point gas 
calibration every fifth. Before and after each test the ambient room air was routinely checked. 
Before the start of the study the validity of the MetaMax II apparatus were tested by 
comparison against Douglas bag and iron lung (Cortex Biophysik). Direct measurements of 
VO2peak are preferable to indirect estimation due to higher precision and reliability
62
. 
However, the methods are more complicated and warrants trained personnel.  
Self-reported information 
Some essential information was questionnaire-based in both HUNT 1 and HUNT 3. In all 
three papers all data on leisure time PA (exercise) were collected through a self-administered 
questionnaire included with the invitation letter. The questions covered the three essential 
domains of PA; frequency, intensity and duration. The frequency question was stated as 
“How often do you exercise?” with the response options “Never”, “Less than once a week”, 
“Once a week”, “2-3 times a week” and “Almost every day”. The intensity question was 
stated as “If you exercise as frequently as once or more a week: How hard do you push 
yourself?”, with the response options “I take it easy without breaking a sweat or losing my 
breath”, “I push myself so hard that I lose my breath and break into sweat” and “I push myself 
near exhaustion”. The duration question was stated as “How long does each session last?”, 
with the response options “Less than 15 minutes”, “15-29 minutes”, “30 minutes to one hour” 
and “More than one hour”. In Paper I and III the individual responses to each question was 
weighted to form a physical activity index score (PA-Index).  The individual weighting was 
chosen on the basis of each variables association with VO2peak in a multiple linear regression 
model. The new index was compared to two previously published PA indexes used in the 
HUNT cohort, but preferred on the basis of a stronger total association with VO2peak. In Paper 
II, the response options were collapsed into categories which roughly corresponded to current 
recommendations for PA for the general population. Inactive people were defined as those 
reporting none or less than once a week of regular PA. The questionnaire applied was the 
same in all three papers, with the exception for the intensity questions used in Paper II. This 
  Material and methods 
 
 
 14 
question was taken from a questionnaire handed out in connection with the VO2peak testing 
and was chosen because it gave more detailed information on relative exercise intensity. 
Participants were asked to assess their usual intensity of exercise on the well-known Borg 6- 
to 20-point scale which is frequently validated against objective measures such as heart rate 
and VO2
90,91
. Other self-reported variables include smoking status (“Never smoked”, “Former 
smoker” and “Current smoker”), alcohol consumption last 14 days (“None”, “1-4 times”, “5-
10 times” and “More than 10 times”), marital status (“Married”, “Unmarried”, 
“Widow/widower” and ”Divorced/separated”), family history of disease and attained 
education (“9 years or less”, “10-12 years” and “More than 12 years”).  
Other register data 
The unique 11-digit identification number allocated to all Norwegian citizens make it possible 
to link data from the HUNT database and other health registries. In Norway, it is mandatory 
for physicians or public health officers to report deaths to the National Cause of Death 
Registry. The underlying cause of death is registered using the International Classification of 
Disease (ICD) coding system. In Paper III, the primary end-point was deaths caused by 
cardiovascular disease (ICD: 9
th
 Revision: 390-459, 10
th
 Revision: I00-I99) and all causes. 
The information on causes of death was complete through December 31
st
, 2010.  
Ethics 
The data collections in all HUNT surveys, including The HUNT Fitness Study and the 
specific studies included in the thesis are approved by the Regional committee for medical 
research ethics, The Norwegian Data Inspectorate and Health Directorate and are performed 
in conformity with Norwegian law and the Declaration of Helsinki. In HUNT 2 and 3 all 
participants signed a document of informed consent, while in HUNT 1 attendance and 
participation in the medical examination was considered as approval of informed consent. The 
mortality follow-up in Paper III was approved by HUNT Research Centre and Statistics 
Norway which is the responsible unity for collection and organization of the data.
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METHODOLOGICAL CONSIDERATIONS 
 
The validity of a study is concerning the degree to which a study reaches a correct conclusion 
and can be broadly separated into internal and external validity. Internal validity is the validity 
of the inferences made as they pertain to the members of the study population while external 
validity is the extent to which the inferences can be generalized to people outside the study 
population (generalizability). In the following the internal and external validity of the studies 
included in the thesis will be discussed. The precision of the specific results (control of 
random errors) are discussed in the Results and discussion section. 
 
Internal validity (control of systematic error) 
Systematic errors in estimates are often referred to as biases, as opposite to validity. Potential 
bias are commonly sub-classified into three different types; selection bias, information bias 
and confounding.  
Selection bias 
Selection bias refers to systematic error introduced by procedures used for selection of 
participants into the study or factors that influence study participation. Such bias appears if 
the relation of the exposure to the outcome is different for those who participate in a study and 
those who theoretically would be eligible for the study
92
. The HUNT studies in general invite 
the total adult population of a county and have a high participation rate and these factors may 
reduce bias due to selection. The participation rate, however, declined somewhat from being 
exceptionally high (89%) in HUNT 1 to a considerably lower, but acceptable in most age 
groups, in HUNT 3 (54%). However, a recent study of attendants and non-attendants in 
HUNT 3 proposed that there is generally no reason to be concerned about biased associations, 
although it depends on the given research question
93
. Moreover, the most pronounced 
difference between attendants and non-attendants were a higher prevalence of cardiovascular 
disease and diabetes among the latter, and these groups were not included in our studies. 
 
The relatively low participation rate in The HUNT Fitness Study (44.7% of those 
invited) may also make Paper I and II subject to self-selection bias. Accordingly, it may be 
possible that those volunteering for exercise testing were also more fit than the corresponding 
healthy sample of non-attendants. However, almost all of those who were invited to testing 
from the basic HUNT study agreed to participate in the VO2peak test. Yet, many potential 
participants chose to withdraw their participation in the study, partly because of long waiting 
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lines due to limited capacity at the test facilities. Nevertheless, a comparison of participants in 
the HUNT Fitness Study and the overall healthy population in HUNT 3 revealed only minor 
mean differences for several important health indicators
88
. For example, in female Fitness 
Study participants systolic blood pressure was 123.5 mmHg compared to 124.3 mmHg in the 
total healthy population, diastolic blood pressure was 69.7 mmHg compared to 69.8 mmHg 
and waist circumference were 0.86 m compared to 0.88 m, respectively. In men, systolic 
blood pressure was 132 mmHg in the Fitness Study sample compared to 131 mmHg in the 
healthy HUNT population and diastolic blood pressure 76 mmHg compared to 75 mmHg. 
BMI were slightly lower in The Fitness Study participants (25.4 compared to 26.1 in women 
and 26.6 compared to 27.0 in men) and a lower proportion reported to be inactive defined as 
exercising less than once per week (14.1% compared to 20.6%). The HUNT Fitness Study 
participants are therefore considered to be fairly representative of the general population of 
apparently healthy, free-living men and women in Nord-Trøndelag County.  
Information bias 
Information bias is commonly arising because of errors or inconsistency in the measurement 
of the exposure or outcome variables. Misclassification is a common source of information 
bias for categorical variables collected from self-report. Misclassification can be differential 
or non-differential depending on the variables relationship to the other variables. Differential 
misclassification occurs when the value of a variable depends on the actual value of another 
variable, while non-differential misclassification implies that the value of a variable is not 
dependent on the actual value of another variable
92
. 
 
All clinical variables measured in HUNT are collected by trained nurses using 
standardized equipment and procedures which consolidates high construct validity. The main 
outcome variable, VO2peak, was measured by ventilatory gas analysis which is considered as 
the gold standard measurement of cardiorespiratory fitness
62
. The non-exercise predicted 
VO2peak, however, are prone to misclassification bias when categorized as in Paper III. The 
misclassification, however, is probably non-differential (i.e. random) which typically leads to 
more conservative or underestimated associations. Another obvious source of information 
bias in the current thesis is the use of self-reported measures of PA.  
Assessment of physical activity (PA) 
Several different methods for assessment of PA are available and the preferred method 
depends largely on the degree of accuracy needed as opposed to the feasibility and cost of the 
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method of choice. For example, the doubly labeled water method are recognized as the gold 
standard method of assessing energy expenditure in free-living individuals, but its expense 
and complicated procedure limits the usefulness in epidemiological settings
62
. This method is 
therefore mostly used to validate less accurate measurement methods such as self-report 
questionnaires. In recent years, however, the introduction of accelerometers and pedometers 
that individuals wear on their hip or arms during daily living has made it possible to measure 
PA quite accurately also in population studies
94
. Self-report measures of PA, as opposed to 
objective measurement, may induce misclassification bias due to a tendency to over- or 
underreporting of a certain behavior due to social desirability or simply because recalling 
specific behaviors is a complex cognitive task. The misclassification caused by incorrect 
recall of PA may be differential (i.e. non-random) if more active people, especially those 
taking part in vigorous PA and sports, are more likely to accurately recall their activity
95
. 
Indeed, the questionnaire applied in Papers I-III was more accurate in measuring vigorous 
than low- and moderate intensity activity in a previous validation study
96
. Furthermore, self-
reported PA has consistently been shown to overestimate the objective level of PA
94
. This 
may indicate bias due to social desirability, suggesting that people tend to over-rate their 
actual PA level. This assumption is reflected in recent studies showing that compliance to PA 
recommendations, as measured by objective methods (accelerometers or pedometers), are 
considerably lower than previous prevalence estimates based on self-report
94
. The estimated 
compliance to the PA recommendations in the general population therefore varies greatly 
depending on how PA is measured. Nonetheless, simple self-report questionnaires have been 
the method of choice in the field of PA epidemiology over several decades. Indeed, most of 
the evidence that form the basis of today`s PA recommendations are based on self-report and 
we can thus conclude that PA questionnaires certainly have contributed to the field of PA and 
health
97
. 
 
However, one must keep in minds that self-report questionnaires and accelerometers in 
essence measures different things. While most questionnaires in general asks the participant 
about a certain behavior, accelerometers merely measures movements. Hence, the 
disagreement between the measurement methods may not just be a question about accuracy. 
The difference may also be attributed to the fact that self-report measurement takes into 
account the interpretation of people about what they really do. For instance, an hour at the 
gym or playing football may not equal an hour of dynamic movement, still the total time 
period engaged in the activity may be the maximum accuracy people are able to recall and 
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interpret. Furthermore, there is at present no consensus about how to translate certain 
accelerometer counts into certain intensities, particularly relative intensity, for different 
groups such as elderly populations. Accordingly, we may speculate that self-report data are 
more easily translated into comprehensible public health guidelines. Moreover, the 
association between objectively measured PA by accelerometers and health outcomes and 
premature mortality is yet to be established. Hence, we might expect that the introduction of 
objective PA measurement in population studies ultimately leads to a shift in the 
recommended amount and intensity of PA for health promotion.  
Confounding 
Confounding is an important issue in observational studies because confounding factors can 
potentially obscure the true association between exposure and outcome. Confounding may 
bias any association observed if one or more variables are associated with the exposure and 
also causally related to the outcome variable
92
. Thus, the effect of the exposure is mixed 
together with the effect of another variable. Confounding therefore introduces bias in studies 
examining cause-effect issues (Paper II and III), but is not of particular concern in pure 
prediction models (Paper I). The error introduced by confounding factors in non-randomized 
studies can be dealt with by statistically controlling for these variables in multivariable 
models (adjustment), by excluding participants at specific levels of the confounding variable 
(restriction) or by doing separate analysis for different levels of the confounder 
(stratification).  
 
The HUNT studies include a wide range of variables that allows for statistical 
adjustment for several potential confounders. Selection of potential confounders and how to 
deal with them is, however, a careful process that should be based on prior knowledge and not 
merely statistical grounds. Age and sex were the most obvious confounders in our studies 
since both are strong determinants of VO2peak and may causally affect both PA levels and risk 
of mortality. Women have systematically lower VO2peak than men across all adult age-groups 
and for the ease of interpretation we chose to stratify our analysis by sex in all studies, instead 
of including sex as a covariate in the linear models. All analyses were adjusted for age. 
Another important confounding factor in most observational studies with recourse to hard-
endpoints (i.e. mortality or cardiovascular disease) is the existence of undetected subclinical 
disease which may lead to biased interpretation of the cause-effect relationship (reverse 
causation). For instance, low VO2peak may be caused by an underlying disease that 
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concurrently increases risk of premature mortality. We cannot fully exclude the possibility of 
this in Paper III. However, the large sample size and broad range of information on baseline 
health status allowed us exclude a large number of participants anticipated to have a 
subclinical disease at baseline (i.e. self-reported long-term functional impairment, motion 
impairment and angina pectoris). Moreover, excluding the first 5 years of follow-up in a sub-
analysis did not change the results appreciably which might have been the case if low-fit 
subjects had the specific diseases already at baseline. 
 
Importantly, a variable that is associated with both the exposure and the outcome 
might be on the causal pathway between exposure and outcome (a mediator) and should then 
not be regarded as a confounder. PA and VO2peak (exposure variables in Paper II and III, 
respectively) positively affects a broad range of factors that may be on the causal pathway to 
the outcome (i.e. VO2peak or cardiovascular mortality) and adjusting for these intermediate 
variables may lead to overly conservative estimates. For instance, we chose not to adjust for 
blood pressure in Paper III since it is well known that PA can reduce blood pressure in a 
causal manner and that blood pressure is causally related to mortality risk
98
. However, we 
excluded participants on blood pressure medication (restriction) although the need for 
pharmacological reduction in blood pressure may be caused by low PA or VO2peak and also is 
known to causally reduce mortality, because medication use might be associated with 
underlying subclinical disease or a genetic vulnerability that increases risk
99
.  
External validity (generalizability)  
Generalizability refers to whether the results apply to people outside the population under 
study. The homogenous nature of the HUNT population, including the HUNT Fitness Study 
sample, may limit generalizability of the results to other populations. Nord-Trøndelag county, 
however, is geographical and demographically representative of Norway as a whole, also 
regarding health
100
. A limitation, however, may be lack of larger cities and a low proportion 
of immigrants of non-European background. However, this non-representativeness is assumed 
to be unrelated to the associations we studied.  The association between CRF and 
cardiovascular or all-cause mortality is well-established, and similarly strong, for a wide 
range of population samples and is therefore probably not confounded by race, ethnicity, 
socio-economic status or geographic residence
33,34,101
. Participants invited to the HUNT 
Fitness Study were apparently healthy, and hence not representative of unselected populations 
normally containing a large proportion of people with cardiovascular or pulmonary diseases. 
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Nevertheless, as compared to previously published data on VO2peak from comparable 
populations, the participants in HUNT had a somewhat higher VO2peak
102-104
. Therefore, the 
lack of an external validation sample is a limitation of Paper I. However, previous studies 
have shown that similar models derived in healthy samples can be applied to groups receiving 
anti-hypertensive medication and people with a positive exercise electrocardiogram
51
. 
Moreover, cross-validation analysis in individuals from the HUNT Fitness Study with 
clustered cardiovascular risk factors (n=224) or hypertension (n=938) indicated that the model 
was valid also when applied to these subgroups. In the hypertensive group of men and women 
the mean difference between measured and predicted VO2peak was negligible and the 
correlation was similar to that observed in the total sample (men, r=0.77, SD 5.58 mL∙kg-
1∙min-1, women, r=0.68, SD 4.84). In the group with a clustering of cardiovascular risk 
factors, as previously defined by Aspenes et al.
27
, the mean difference were 0.5 mL∙kg-1∙min-1 
(r=0.77, SD 4.87 mL∙kg-1∙min-1) Hence, the non-exercise model may be applicable also to 
high-risk subjects although derivation of population specific models may be preferable. 
Statistical analyses 
Paper I and II were designed as cross-sectional studies and included participants from the 
HUNT Fitness Study. Paper III was a prospective follow-up study of apparently healthy 
participants in HUNT 1. Analyses were done separately for men and women in all three 
papers. Precision of estimated means and hazard ratios were indicated by 95% confidence 
intervals. All statistical p-values were two-sided and the statistical procedures were conducted 
using PASW Statistics version 18.0 (Copyright 1993-2007 Polar Engineering and Consulting) 
or STATA for Windows version 12.1 (StataCorp LP, 1985-2007). 
 
In Paper I, multiple linear regression analyses with VO2peak as the dependent variable 
were used to develop the non-exercise models. Inclusion of potential predictor variables were 
done hierarchically, meaning they were entered one by one or in blocks of two or more 
variables based on a priori assumptions of the variables` association with VO2peak. This 
method is preferable because the investigator easily can control the entry of predictor 
variables based on theoretical considerations
105
. An alternative regression method could be 
stepwise or backward regression which allows the computer program to select a set of the 
“best” predictors based on correlation coefficients. This approach, however, has several 
pitfalls because it is entirely data driven and the obtained model may not be the optimal 
regarding both internal and external validity
106
. Two important statistical measures were used 
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to evaluate the accuracy of the models, namely the standard error of estimate (SEE) and the 
squared multiple regression coefficient (R
2
)
107
. SEE refers to the random error of prediction 
for a regression line and are equal to a standard error score of 1 in terms of the units of the 
dependent variable. SEE is calculated as the sum of squared differences between actual and 
predicted values, divided by the total number of subjects. On the other hand, R
2
, also called 
the coefficient of determination, is a measure of the strength of association and tells us what 
proportion of the variation of a variable (i.e. VO2peak) that can be explained by a set of 
predictor variables. The models were further examined for accuracy by examining subgroups 
of age, PA-level and VO2peak for constant errors (CE) and total errors (TE). CE are a measure 
of systematic over- or under-prediction and were calculated as the mean difference between 
measured and predicted VO2peak (mean residuals) within the subgroups. A negative CE value 
indicates that the model, at average, tended to overestimate VO2peak in that particular 
subgroup, while a positive value indicates a potential under-prediction. In contrast, TE 
combines the systematic error and the random error (SEE) and represents the total error of the 
model when applied to the particular subgroup. Any systematic over- or under-prediction 
among subgroups could be corrected by adding or subtracting the appropriate CE value from 
a cross-validation statistics for a particular sub-group, to the y-intercept of the original 
equation. Theoretically, this method would result in a constant error of zero for the modified 
equation when used in the intended population
108
.  To test this hypothesis a cross-validation 
study in an independent sample would be necessary. The final model was, however, internally 
cross-validated by splitting the data-set into a derivation and a cross-validation sample. The 
regression analysis was performed on the derivation sample and the obtained model used to 
predict VO2peak for each individual in the cross-validation sample. The correlation between 
observed scores and the predicted scores constitute the cross-validity coefficient which were 
squared and compared to the original R
2
 of the validation sample. CE and TE values were 
estimated for the cross-validation sample when the model obtained from the derivation 
sample was used. Here, CE and TE represent the systematic and total error values of a model 
derived in one sample and validated in another sample. PRESS-statistics (Predicted Residual 
Sum of Squares) represents an alternative to simple-data splitting as an internal cross-
validation procedure. This method may be preferable to data-splitting in smaller samples 
because it allows all observations to be included in both derivation and cross-validation. 
When the PRESS procedure was applied to the data material in Paper I we observed a R
2
 of 
0.61 and 0.55 and a SEE of 5.71 and 5.15, in men and women, respectively. Hence, this 
method did not add anything to simple data-splitting in the present cohort. 
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In Paper II, a general linear model (GLM) was used, with VO2peak as the dependent 
variable, to determine the association between different groups of self-reported exercise 
patterns and VO2peak. Adjustment was made for age only or age, BMI, smoking status and 
occupational PA. From the sub-maximal steady-state VO2-measures and the VO2peak-test, the 
test-subject’s individual perceived exertion on the Borg scale association with VO2 was 
calculated (Y = a∙X + b, where Y is VO2 and X is Borg). For a given Borg scale rating a 
corresponding VO2 value as a percentage of VO2peak was established based on the individual 
treadmill test. The individual energy expenditure during self-reported exercise was calculated 
by multiplying the VO2 (L∙min
-1
) corresponding to the self-reported Borg scale rating by 5 
kcal∙min-1 (equivalent to ~1 L VO2 for 1 minute). Furthermore, average energy expenditure 
was multiplied by the self-reported weekly duration of exercise to estimate total energy 
expenditure. Estimated resting energy expenditure was subtracted to obtain an estimate of net 
energy expenditure caused by exercise. In order to assess the independent effect of relative 
intensity within groups with different net energy expenditure, VO2peak was entered as a 
dependent variable and intensity groups as independent variable with estimated weekly 
energy expenditure (kcal/week) and age as continuous variables as covariates. The analyses 
were then done separately for quartiles of weekly energy expenditure. Hence, we could 
separate the effect of intensity independent of its contribution to total energy expenditure. An 
implicit limitation of this cross-sectional study is that it cannot suggest causal pathways, but 
merely indicate associations and this limitation has to be acknowledged when interpreting the 
results
109
. 
 
In Paper III, Cox-proportional hazard models were used to assess the association of 
mortality with estimated VO2peak.  The Cox-model offers the opportunity to include numerous 
covariates and hence efficiently control for confounding. The outcome variables were death 
from cardiovascular disease and death from all-causes. We adjusted for age by entering age as 
the time-scale. Using age as the time-scale instead of time-on-study limits the introduction of 
bias than can occur when age is highly correlated with the predictor variable of interest, which 
is the case with estimated VO2peak. We also did stratified analysis for younger and older 
subjects due to a moderate effect modification by age 60. Effect modification may appear 
when the influence of two variables on the outcome variable are not additive in their 
respective effects (i.e. the association between estimated VO2peak and mortality were different 
for younger and older subjects). The validity of the prediction models were assessed by 
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examining measures of discrimination and calibration
110
. Discrimination was assessed by 
calculating the area under the receiver operating curves (AUC, also known as Harrell`s c-
statistic) and its 95% confidence intervals for estimated CRF and each modifiable constituent 
component, respectively. The AUC describes the probability that a classifier will assign a 
higher risk to a randomly chosen participant who died than a randomly chosen participant 
who survived until end of follow-up. Hence, a risk prediction by pure chance yields a c-
statistic of 0.50, and higher values reflect better discrimination. The calibration refers to the 
degree of similarity between the observed and predicted risk (i.e. low-fit participants with a 
given predicted risk will actually experience events at the same rate). The Cox-regression 
model was calibrated by comparing the mean incidence proportion of events (CVD and all-
cause, respectively) for each quintile of predicted risk and each estimated VO2peak-group, with 
the multi-adjusted predicted risk obtained by the Cox-models.
  Results and discussion 
 
 
 24 
RESULTS AND DISCUSSION 
 
The current thesis shows that peak oxygen uptake (VO2peak) can be predicted with reasonable 
accuracy from easily available clinical and self-reported variables. The final multiple 
regression model (non-exercise model) could predict long-term cardiovascular and all-cause 
mortality in people who were apparently healthy and below 60 years at baseline. Furthermore, 
we demonstrate that habitual exercise patterns of moderate relative intensity for a long total 
duration or vigorous intensity for a relatively short duration, adding up to the total volume as 
recommended by the health authorities, both were associated with a beneficial VO2peak –level.  
Non-exercise models of peak oxygen uptake 
To our knowledge, the non-exercise models in Paper I are the first developed in a 
Scandinavian population and among the few derived from a large sample that included similar 
amounts of men and women with directly measured VO2peak as the outcome variable. The 
accuracy of these models, as judged by R
2
 (0.61 and 0.56 for men and women, respectively) 
and SEE (5.7 and 5.1 for men and women, respectively), are comparable to previously 
published models containing similar, large samples and a wide age range (Table 1)
51,54,104,111
. 
Non-exercise models that report considerably lower SEE and higher R
2
 were generally based 
on smaller and more selected samples and may therefore have limited generalizability
112,113
. A 
large sample size is crucial for obtaining a useful prediction equation
114
. More predictor 
variables applied to smaller samples may spuriously increase the explanatory power
107
. The 
vast majority of previous non-exercise models include the variables sex, age, PA level and 
body composition, while some also include smoking, resting heart rate or height
51,54,115
. The 
non-exercise model in Paper I differ from most previous studies in that we made sex-specific 
models instead of including a dummy-coded sex variable. Sex differences in body 
composition are well-documented and may support sex-specific models as long as the sample 
size is large. Moreover, inclusion of product terms revealed interactions with sex for age, BMI 
and WC, respectively, which further support the preference of sex-specific models. Although 
WC/BMI was the strongest modifiable predictor in our sample, habitual PA levels are a key 
determinant of CRF and should therefore be measured with precision. In an attempt to 
improve the accuracy of prediction, Japanese researchers have included objective assessment 
of PA in their prediction models
116,117
. Hence, they would possibly overcome the 
accompanying bias associated with self-report measures of PA.  When including time spent in 
moderate-to-vigorous PA or limited to vigorous PA as measured by accelerometers together 
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with age and BMI or waist circumference, respectively, they observed a considerably higher 
R
2
 and lower SEE compared to previous models (R
2
, 0.71-0.86, SEE, 3.0-4.2). However, to 
obtain an objective measure of PA, it is required that the individual wears an activity monitor 
for up to 7 consecutive days, which may not be feasible in most healthcare settings
118
. 
 
In Paper I, we instead attempted to make a PA index from self-reported data that 
correlated well with VO2peak. Hence, we examined the independent contributions of 
frequency, duration and intensity of PA and weighted each PA dimension differently 
according to the obtained ß-coefficients in a multiple regression analysis. It is proposed from 
several large-scale studies that intensity of PA are more strongly associated with VO2peak than 
frequency or duration
60,75
. The index takes this into account by weighting higher relative 
intensity more than higher frequency and duration of PA, respectively (see Table 4 in Paper 
I). The correlation between the PA-Index and VO2peak were 0.39 and 0.44 in women and men, 
respectively. We might, however, speculate that questionnaires making use of absolute 
intensity (activities assumed to require a certain energy expenditure), are more suitable in 
predicting VO2peak since the absolute intensity during exercise are inherently limited by the 
maximal exercise capacity. For example, the Duke Activity Status Index (DASI) asks 
participants about their ability to perform 12 common daily activities that requires different 
levels of functional capacity. This index has been shown to correlate moderately well (r=0.58) 
with directly measured VO2peak in an independent sample of healthy subjects
119
. Similarly, the 
Veterans Specific Activity Questionnaire (VSAQ) lists 13 activities with a corresponding 
MET-value and was shown to correlate moderately well with VO2peak (r=0.42) in people 
referred for exercise testing for clinical reasons
120
.
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In the model used for prospective mortality follow-up (Paper III), BMI was used instead of 
WC as a measure of body composition since WC was not measured in HUNT 1. However, 
both variables were examined extensively during the derivation of the model and yielded only 
small differences in R
2
 and SEE as shown in Table 2. Previous studies have shown that 
inclusion of waist or BMI in multivariable models did not change model characteristics 
substantially
115,121
. Noteworthy, BMI was a strong predictor of VO2peak, despite that VO2peak 
were defined as the amount of oxygen consumption per kilo body mass (mL∙kg-1∙min-1). The 
finding that BMI were highly associated with VO2peak may indicate that simply dividing VO2 
by body mass do not fully account for the influence of body mass on VO2peak as intended.  
Some studies have also examined the predictive ability of percent body fat in non-exercise 
models and found similar or slightly better model fit
112,115,122
. However, percent body fat is 
estimated by measuring thickness of a minimum of three skinfolds and a possibly higher 
precision may not justify the time requirement needed to measure it properly.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The accuracy of the present models, in terms of SEE and R
2
, are comparable to submaximal 
exercise testing of VO2peak. For example the Multistage shuttle run test
123,124
, the Rockport 1-
mile walk test
125
, the modified Bruce protocol
45,126
, the single-stage submaximal treadmill 
test
127,128
, the Åstrand-Rhyming test
46,129
 and the ACSM prediction equation
130
 all report SEE 
within the range of 3.5 to 6.5 mL∙kg-1∙min-1. However, most submaximal tests are population-
specific and direct comparison may be limited without thorough cross-validation of both 
methods in an independent sample. We are aware of two other studies that validated non-
Table 2: Multiple regression coefficients for predicting VO2peak (mL·kg
-
1
·min
-1
) in the total sample with waist or BMI included in the model 
Variable Men  Women 
 WC-model BMI-model  WC-model BMI-model 
Intercept 100.27 92.05  74.74 70.77 
Age -0.296 -0.327  -0.247 -0.244 
PA-Index 0.226 0.257  0.198 0.213 
WC/BMI -0.369 -0.933  -0.259 -0.749 
RHR -0.155 -0.167  -0.114 -0.107 
R 0.782 0.770  0.745 0.753 
R
2
 0.612 0.593  0.555 0.568 
SEE 5.70 5.84  5.14 5.06 
PA-Index, physical activity index, WC, waist circumference,  BMI, body mass index RHR, 
resting heart rate, R, multiple regression coefficient, R2, squared multiple regression 
coefficient, SEE, standard error of estimate 
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exercise testing models and submaximal testing methods in the same sample. Jackson et al. 
(1990) reported similar correlations with directly measured VO2peak for their non-exercise 
model (r=0.79), compared to the Åstrand-Rhyming submaximal test (r=0.78), in a healthy 
cross-validation sample
51
. However, the submaximal exercise test considerably overestimated 
VO2peak for the whole range of fitness levels, while the non-exercise model underestimated 
VO2peak among high-fit subjects. Mailey et al. (2010) validated the non-exercise model from 
Jurca et al. (2005) in elderly subjects, and found fairly similar cross-validity correlations 
between VO2peak and maximal METs estimated from the non-exercise model (r=0.66) and the 
Rockport 1-mile walk test (r=0.68), respectively
55
. Moreover, the non-exercise model was 
more closely related to cardiovascular risk factor clustering compared to the Rockport test
55
. 
 
One reason why non-exercise models, as well as submaximal testing methods, fail to 
fully account for the variance in directly measured VO2peak may be that the individual 
variability attributed to genetics are high. Several lines of evidence suggest that heritability 
may be responsible for more than 50% of the variability of VO2peak in heterogeneous 
populations
72
. This is congruent with the results in Paper I, and others
45,51,54
, showing that 
~40% of the variance are left unexplained after including a wide range of modifiable and non-
modifiable predictor variables. CRF are, however, frequently measured by maximal treadmill 
tests that, in comparison to sub-maximal and non-exercise tests, may better capture the 
heterogeneity in VO2peak
45,131
. These protocols have been used in epidemiological studies and 
yield fairly accurate estimates of VO2peak (r~0.90, SEE~3-4.0 mL∙kg
-1∙min-1)132. However, 
these protocols suffer from many of the same limitations as direct measurement in terms of 
time-use, personnel requirement, equipment and participant efforts. 
 
A possible limitation of most established non-exercise models is that they were 
derived from cross-sectional data. Therefore the accuracy of these models to estimate 
temporal changes in VO2peak is not known. Accordingly, one does not know whether changes 
in the modifiable predictor variables over time, by training or detraining, may be detected by 
non-exercise prediction of VO2peak. Furthermore, most cross-sectional models, including ours, 
found that VO2peak was linearly related to age and hence included age as a linear term. 
However, longitudinal VO2peak data suggest a non-linear decline with increasing age
133,134
. A 
recent study from the ACLS cohort attempted to overcome these problems by developing 
models from longitudinal exercise test data using linear mixed models
122
. These models are 
promising for capturing temporal changes in VO2peak and warrants further attention.  
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Cross-validity of the model 
Given the SEE of the current models (5.7 and 5.1 mL∙kg-1∙min-1 for men and women, 
respectively) there is a relatively wide scatter around the line of identity for measured and 
predicted values. Implicitly, a predicted VO2peak for an individual will be lower or higher than 
the true value in most participants. Moreover, the degree of inaccuracy may further increase 
when a model derived from a given population are applied to a different population. 
Therefore, different cross-validation techniques are commonly used to estimate how 
accurately a predictive model will perform in an independent data set. Such methods are 
important in guarding against a spuriously high model-fit that may appear when multiple 
predictors are included in a regression model. The problem of over-fitting a model can be 
detected by simple data-splitting procedures as presented in Paper I. Here, the regression 
model was developed on a randomly drawn part of the sample and tested on the other half of 
the sample.  
 
Overall, the cross-validation statistics revealed high model stability as evidenced by 
small differences between measured and predicted values and relatively stable total error, 
across subgroups of age and PA levels in both sexes (see Table 5 in Paper I). The model 
seems to be most accurate among those with a medium fitness level reporting none or mostly 
low-intensity PA and those who were above 35 years for men and 50 years for women. 
However, in accordance with previous studies
51,104
, the model tended to overestimate VO2peak 
in low-fit subjects and subsequently, underestimate VO2peak in high-fit subjects. When the 
model was applied to the cross-validation sample it tended to underestimate and overestimate 
VO2peak, respectively, by at average ~4-5 mL∙kg
-1∙min-1 in low- and high-fit men and women.  
 
 
  
  Results and discussion 
 
 
 31 
 
 
 
 
 
 
 
 
 
 
 
 
Cross-classification 
In a health perspective the systematic under-prediction among high-fit subjects may not 
sustain a pressing problem, because moderate and high fitness is not associated with high 
disease risk. At the extremes of CRF, such as among heart disease patients or top level 
endurance athletes, VO2peak should be directly measured with regularity because relatively 
small increments/decrements may have great impact on prognosis or performance
135
. The 
ability to easily and correctly classify low-fit apparently healthy subjects, however, is of 
crucial importance since several dose-response studies suggest that the largest increase in risk 
are between low-fit and medium-fit persons
28,39
. We evaluated the ability of the non-exercise 
models to classify an individual`s VO2peak by cross-classification procedures. In Paper I we 
show that the model was quite accurate in classifying high- and low-fit subjects since ~90% 
of the participants were correctly classified into the same or adjacent quartile of measured 
VO2peak (see Table 6, Paper I). In practice this implies, given that the quartile cut-points are 
used, that a woman with a predicted VO2peak below 32 mL∙kg
-1∙min-1 probably has a measured 
VO2peak at least below 35 mL∙kg
-1∙min-1 and a man with a predicted value below 40 mL∙kg-
1∙min-1 is very likely to have a measured VO2peak below 44 mL∙kg
-1∙min-1. In a previous study 
from the HUNT Fitness Study, Aspenes et al. showed that men and women with a measured 
VO2peak below 44 mL∙kg
-1∙min-1 and 35 mL∙kg-1∙min-1, respectively, had an increased 
prevalence of cardiovascular risk factor clustering
27
. Hence, we might be able to capture high-
Table 4: Age and sex-specific quintile cut-off values for 
measured VO2peak (mL∙kg
-1∙min-1) 
 Total sample <60 years ≥60 years 
Men    
Q1 <36.1 <38.9 <31.6 
Q2 36.1-41.5 38.9-44.2 31.6-34.8 
Q3 41.5-46.5 44.3-48.5 34.9-39.1 
Q4 46.6-52.0 48.6-53.5 39.2-43.4 
Q5 >52.0 >53.5 >43.4 
Women    
Q1 <29.1 <31.2 <25.0 
Q2 29.1-33.3 31.2-34.9 25.0-27.9 
Q3 33.4-37.2 35.0-39.1 28.0-30.7 
Q4 37.3-42.0 39.2-43.2 30.8-33.8 
Q5 >42.0 >43.2 >33.8 
Q1-5, quintiles of measured VO2peak 
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risk subjects by using the right cut-offs. The distribution of some cardiovascular risk factors 
stratified by quintiles of estimated VO2peak in the HUNT Fitness Study participants is shown 
in Table 3. Several clinical cardiovascular risk factors differ in a dose-response manner across 
estimated VO2peak categories. In the following we show that the model was reasonably 
accurate in cross-classifying low-fit subjects into the correct tail of the measured VO2peak 
distribution (i.e. 1
st
 and 2
nd
 quintile). The age- and sex-specific cut-off values for measured 
VO2peak in the total sample and men and women above and below 60 years are presented in 
Table 4.  
 
 Table 5 shows cross-classification of low-fit participants (1
st
 quintile of measured VO2peak) 
across quintiles of predicted VO2peak based on the BMI-model. Hence, the percentages 
represent the sensitivity of the model to capture those with a low measured VO2peak. In the 
total sample slightly above 40% were correctly classified into the lowest quintile. However, 
more than 80% were correctly classified within one quintile. Hence, a predicted VO2peak 
below 41.5 and 33.3 mL∙kg-1∙min-1 in men and women, respectively, would capture most 
participants with a measured VO2peak below 36.1 and 29.1 mL∙kg
-1∙min-1. Extreme 
misclassification occurred very rarely as only 2.2 and 3.6% of the low-fit men and women, 
respectively, were predicted to be in the two highest categories of VO2peak. In subgroups the 
non-exercise model were, as expected, less accurate in classifying low-fit subjects of normal 
weight and those reporting a high PA level. However, a relatively few subjects fell into these 
categories (n=63 and n=111 for normal weight men and women, respectively and n=25 and 
n=23 for highly active men and women in 1
st
 quintile of VO2peak). On the other hand, the 
majority of subjects who were predicted to be in the lowest quintile actually had a measured 
VO2peak in the 1
st
 (~70% in both men and women) or 2
nd
 quintile (>90% in men and women). 
Only 1-2% of those predicted to have low fitness did actually have a VO2peak in the two 
highest quintiles. Therefore, we can be relatively confident that those with a low predicted 
VO2peak actually has a low VO2peak (high positive predictive value). These numbers are in 
accordance with two previous studies that evaluated the classification accuracy of non-
exercise testing
104,136
. Hence, we considered the model as accurate enough to correctly 
identify low-fit and high-fit subjects in an epidemiological study (Paper III). 
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Table 5: Cross-classification of participants with low measured VO2peak into categories of predicted VO2peak 
 Classification into predicted quintiles (%) 
 Men  Women 
Low measured 
VO2peak (Q1) 
N
a
 Q1 Q1-2 Q4-5  N
a
 Q1 Q1-2 Q4-5 
Total sample 414/2067 41.5 84.0 2.2  439/2193 42.8 80.4 3.6 
 <60 years
b
 321/1601 45.5 86.0 2.8  349/1745 36.1 73.6 5.5 
≥60 yearsb 94/466 50.0 72.3 5.7  90/448 43.3 66.6 15.5 
Low activity
c
 247/759 51.8 89.0 1.6  254/795 56.3 87.4 2.0 
Moderate activity
c
 142/954 28.2 81.9 2.1  162/1038 26.5 72.2 6.2 
High activity
c
 25/354 16.0 48.0 8.0  23/360 8.7 60.9 4.3 
Normal weight
d
 63/644 12.7 63.5 4.8  111/1182 13.5 62.1 12.6 
Overweight
d
 222/1143 36.5 85.1 2.7  182/733 37.4 78.6 1.1 
Obese
d
 129/280 64.3 92.2 0.0  146/278 71.9 96.6 0.0 
Q1-5, quintiles of predicted VO2peak  
a
number in lowest quintile of VO2peak and total number in subgroup 
b
age-specific quintile from Table 4 
c
Tertiles of PA-Index 
d
BMI <25 (normal), 25-30 (overweight), >30 (obese) 
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Estimated VO2peak and mortality 
In Paper III we used the non-exercise model of Paper I to estimate VO2peak in a large sample 
of healthy men and women who took part in the first HUNT Study in 1984-85. Furthermore, 
we assessed the association with all-cause and cardiovascular mortality after ~24 years of 
follow-up. Previous population-based studies have confirmed that exercise tested CRF is a 
powerful and independent predictor of premature mortality in asymptomatic 
populations
24,28,137
 and in people with cardiovascular disease
24,34,36,138
. Assuming that the non-
exercise model were able to correctly classify VO2peak in an independent sample from the 
HUNT population, we hypothesized an increased risk of mortality among those estimated to 
have low VO2peak at baseline and an overall inverse association between mortality and 
estimated VO2peak. 
 
Indeed, the observed risk reductions associated with higher estimated VO2peak in 
participants below 60 years at baseline, were comparable to those obtained in population 
based studies that estimated CRF from maximal treadmill tests
24,31
. A meta-analysis by 
Kodama and co-workers reported a summarized risk reduction for all-cause mortality of 13% 
per MET (~3.5 mL∙kg-1∙min-1) higher CRF31. Among the 19 studies that were included, the 
reported risk reductions ranged from 4 to 26% per MET higher CRF. Hence, our findings of 
8-14% reduction in all-cause mortality and 21% reduction in cardiovascular mortality per 
estimated MET seem to be well within the expected range. In participants below 60 years, we 
observed a 12 and 17% lower risk of all-cause mortality and ~25% lower risk of 
cardiovascular mortality in men and women, respectively, with medium CRF compared to 
those in the lowest quintile. It could be argued, however, that prediction of mortality from a 
non-exercise model does not provide more information than what is already available from 
the respective variables included in the model (i.e. age, BMI, PA and RHR). In Paper III, 
however, we show that estimated VO2peak had a better discriminative ability than each of its 
constituent components separately, also when age was statistically controlled for. This may 
not be surprising since BMI, PA, RHR are all independent predictors of premature 
mortality
139-141
. However, estimated VO2peak was also a better predictor than a composite 
score derived from the sum of z-scores for each variable. Consequently, we might propose 
that the non-exercise model were able to discriminate participants by VO2peak and therefore 
might add to the prognostic utility of each separate risk factor. 
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Only one other study has examined the association between estimated CRF from a 
non-exercise model and premature mortality. Stamatakis and co-workers used one of the 
models from Jurca et al. to estimate CRF in 32,319 healthy men and women
142
. In general, 
their findings of a 12-15% decrease in all-cause and 25-27% decrease in cardiovascular 
mortality per SD increase in estimated METs (SD was ~1.6-1.7 METs) are close to those 
obtained in Paper III. That study pooled data from eight different cohorts and had a shorter 
follow-up time (~9 years). The prognostic utility of non-exercise testing of CRF should be 
evaluated further in other populations. A few other studies have, however, attempted to 
predict premature mortality from more simple CRF estimates without performing exercise 
testing. Among 906 women referred for coronary angiography, maximal METs estimated 
from the DASI questionnaire predicted adverse cardiovascular events and all-cause 
mortality
143
. Each estimated MET was associated with an 8% decrease in risk of adverse 
cardiovascular events and 7% decrease in risk of all-cause mortality. Similarly, a study that 
estimated METs from the VSAQ questionnaire during a mean follow-up of 4.5 years, 
reported a 10% survival benefit during per each MET in 1185 men referred for exercise 
testing for clinical reasons
144
. Moreover, a prospective cohort study including 858 middle-
aged participants from Scotland found that self-rated fitness were an independent and 
similarly strong predictor of all-cause mortality as self-rated overall health status
145
. Although 
the risk reductions reported in these studies were generally lower compared to Paper III and 
that from Stamatakis et al., and may vary according to baseline hazards, the findings at least 
suggest that including self-rated fitness levels may increase the accuracy of future non-
exercise models and their association with hard endpoints. 
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Intensity and volume of physical activity in relation to health outcomes 
Today`s recommendations for PA allows for shorter total duration of PA spend at vigorous 
intensities or longer total duration of moderate intensity as long as the total volume exceeds 
~500 MET/min per week (minutes per week ∙ intensity in METs, corresponds to ~1000 kcal). 
An implication of this statement is that the benefits of higher intensity, as opposed to low or 
moderate, are attributed essentially to the higher energy expenditure per time unit. However, 
accumulating evidence from randomized trials indicate that high intensity training may yield 
health benefits independent of its contribution to the total energy expenditure
85,146
. Some 
epidemiological evidence are also emerging, including a large prospective cohort study 
involving 416,175 individuals that were followed for ~8 years
86
. In that study, self-reported 
PA was separated into moderate and vigorous intensity for five different categories of total 
weekly energy expenditure. For a similar or lower estimated energy expenditure, reporting 
vigorous intensity activities was associated with lower risk of death from cardiovascular 
disease, diabetes and all-causes. Moreover, a study of men in the Health Professionals` 
Follow-up Study found a significantly lower risk of coronary heart disease for vigorous 
compared to low and moderate intensity after statistically controlling for total energy 
expenditure
147
. Also, a previous HUNT study showed that a single weekly exercise session of 
high intensity considerably reduced the risk of cardiovascular mortality compared to no 
activity, while no additional benefit was observed by increasing the duration or frequency of 
exercise sessions
148
.  
  
However, it is suggested that self-reported PA by questionnaires are more imprecise in 
measuring low and moderate intensity exercise (misclassification bias) and we might suspect 
that most people who are doing vigorous intensity activity also do considerable amounts of 
moderate intensity activity
95
.  Hence, the inability to separate the effects of high and moderate 
intensity activity in relation to health outcomes has been a problem of observational studies. 
The incorporation of objective measurement of PA by accelerometers in population based 
studies, however, may be superior to self-report measures concerning the independent effects 
of moderate and vigorous intensity PA. Recently, Jansen and Ross showed that vigorous 
intensity PA measured by accelerometers had a considerably larger influence on metabolic 
syndrome prevalence compared to moderate intensity PA after controlling for total energy 
expenditure dose
149
. Intriguingly, ~75 min of vigorous PA had double the benefit of ~150 min 
of moderate PA when energy expenditure was kept constant. 
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Intensity and volume of exercise in relation to peak oxygen uptake (VO2peak) 
Several short-term randomized controlled trials have indicated that vigorous intensity 
exercise, relative to the individual`s VO2peak or maximal heart rate, yield larger improvements 
in VO2peak than moderate intensity exercise for a similar amount of total work performed
150-
153
. For practical reasons randomized trials generally mimic only two or three out of an 
infinitely number of possible exercise patterns (i.e. combinations of frequency, duration and 
intensity) in free-living individuals. Furthermore, such trials are hampered by relatively short 
follow-up time (solely <1 year, usually 8-12 weeks) and small and/or selected samples. 
Whether these benefits are maintained over a longer time frame, i.e. over the course of a 
lifetime, and hence relevant for public health guidelines, is therefore a matter of controversy. 
On the contrary, observational studies may better capture more permanent PA behavior and 
provide complementary information on dose-response issues. In Paper II, we cross-sectionally 
examined how self-reported, freely selected exercise patterns of longer total duration at 
moderate intensity and shorter durations at vigorous intensity were associated with VO2peak in 
healthy adults. Briefly, similar VO2peak was observed in groups approximating those patterns, 
but considerably higher net estimated energy expenditure were found among the longer 
duration-moderate intensity groups. Interestingly, however, groups reporting shorter exercise 
time than recommended (i.e. less than 75 minutes per week, mean ~45-50 minutes) at 
vigorous intensity, had comparable VO2peak values to those in the moderate intensity-long 
duration groups. Despite this, the energy expenditure was considerably lower than the total 
recommended volume. Possible dose-response relationships between PA at low, moderate and 
vigorous intensity and VO2peak from these data are shown in Figure 3 and 4.  Our observation 
of substantially higher VO2peak levels among those reporting vigorous-intensity, as compared 
to moderate and low intensity at similar total duration, is in accordance with data from 
randomized controlled trials
57,76
 (Figure 3, see also Figure 1 in Paper II). Although not 
essentially novel, this information is important since lack of time is one of the most stated 
barriers to habitual exercise
154,155
. The intensity-dependent associations were, however, 
attenuated after adjusting for weekly net energy expenditure (Figure 4, see also Figure 2 in 
Paper II). In men, VO2peak was still slightly higher for vigorous intensity PA, as compared to 
moderate intensity at all total volumes performed. Among women, however, at least the 
recommended total volume of 1000 kcal∙week-1 seemed to be necessary to achieve benefits 
from vigorous intensity PA when net energy expenditure was constant between the two 
intensity groups.  
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In Paper II we assessed the intensity of exercise using the Borg 6-20 scale. The Borg 
scale is considered as a valid measure of relative intensity and correlated well with relative 
VO2 and heart rate at different stages of incremental treadmill walking or running in the 
present population. Contrary to the majority of observational studies, intensity of exercise was 
therefore assessed relative to the individuals` exercise capacity not in absolute MET 
values
124,125
. This may be more appropriate when the age-span is large and CRF levels differ 
widely among participants. For example, an absolute intensity of 7 METs (VO2 ~25 mL∙kg
-
1∙min-1) corresponded to 82% of VO2peak, and 14-15 on the Borg scale (vigorous intensity) for 
an average 60-year-old woman, while it corresponded to only 45% of VO2peak  and Borg scale 
8-9 (low intensity) for a 20-year-old man among the participants in Paper II. Hence, 
undertaking PA requiring 7 MET may yield a substantially different exercise stimulus at 
different tails of the CRF distribution. Hence, the perceived exertion of activities requiring a 
certain absolute intensity may be negatively associated with the individuals` level of CRF
156
. 
Moreover, it is practically important because current guidelines support perceived exertion as 
the primary method in exercise prescription
2,140,157
. Paper II was also novel in that we 
estimated self-reported PA energy expenditure on the basis of the concurrent VO2 associated 
with each individual`s Borg scale ratings at the incremental treadmill test. Previous studies 
have provided crude estimates of energy expenditure from self-report data by assigning 
certain MET values to specific activities based on the compendium by Ainsworth et al
158,159
. 
Hence, we used a more direct approach in determining individual energy expenditure. 
However, we acknowledge that people may rate the exertion different in a test setting as 
compared to recalling usual exercise intensity in daily life. Hence, the estimated energy 
expenditure may be subject to bias when translating perceived exertion on the treadmill to 
habitual exercise. However, reporting a shorter total duration and/or lower intensity than 
recommended was consistently associated with estimated net energy expenditure below 1000 
kcal∙week-1. Moreover, a doubling of total time spent within the different intensity groups was 
associated with an approximately doubling of net energy expenditure (see Table 4 in Paper 
II). 
 
The findings in Paper II in no way negate current PA recommendations, but suggest 
that vigorous relative intensity certainly compensates for lower total exercise time and may 
also be beneficial to moderate intensity PA at similar net energy expenditure, at least in men 
and active women. Indeed, the observed differences in VO2peak may seem small, but as 
previously mentioned, a difference of 1 MET (~3.5 mL∙kg-1∙min-1) may provide a reduced 
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relative risk of premature mortality in the order of 10-25% which must be considered as a 
clinically relevant difference
31
. Broadly recommending sporadic vigorous intensity exercise 
may, however, be controversial due to possible increased risk of musculoskeletal injury and 
triggering of heart attacks in subgroups with underlying disease
160,161
. Furthermore, the 
modest estimated energy expenditure in the low volume-vigorous intensity groups may not be 
sufficient for preventing weight gain
162
. Hence, reducing sedentary time and, accordingly, 
accumulating low intensity activity through daily life activities should be highly encouraged 
in addition to exercise training and may yield health benefits independent of increased 
VO2peak
163,164
. Furthermore, the results herein may be explained by relatively fit people being 
more likely to engage in more frequent and/or more vigorous PA. Hence, causality can only 
be determined by large-scale randomized trials with careful control of exercise behavior and 
drop-outs.  
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Figure 3: Weekly exercise time and VO2peak in men and women at different intensities. Low intensity (Borg scale 6-11, ~40-65% of 
VO2peak), moderate intensity (Borg scale 12-13, ~70-72% of VO2peak) and vigorous intensity (Borg scale 14-20, >80% of VO2peak). 
The curves were smoothed through the mean VO2peak for groups reporting different total exercise time at low-, moderate and 
vigorous intensity, respectively. 
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Figure 4: Total kcal per week spent at exercise and VO2peak in men and women at different intensities. Moderate intensity (Borg 
scale 12-13, ~70-72% of VO2peak) and vigorous intensity (Borg scale 14-20, >80% of VO2peak). The curves were smoothed through 
the mean VO2peak for groups with different energy expenditure at moderate and vigorous intensity, respectively. 
 
Practical application of the results 
The current thesis may provide an opportunity for physicians and other health personnel to 
put focus also on the individual level of CRF in clinical consultations. The non-exercise 
model from Paper I can easily be incorporated in computer programs that estimates the CRF 
level (see www.ntnu.no/cerg/vo2max) or in prediction charts (see Appendix). When a low 
level of CRF is identified a maximal exercise test using ventilatory gas analysis could be 
considered to objectively determine VO2peak and provide an accurate baseline level before 
eventually entering a structured exercise program. However, one should be aware that the 
estimation are limited in capturing individuals who are low-fit despite of being highly active 
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and of normal weight etc. (potentially so-called non-responders). A conversation about the 
agreement between self-rated fitness and self-reported exercise patterns may help in detecting 
these relatively rare cases. Furthermore, focus should be set on the major modifiable 
determinant of CRF, namely the habitual PA pattern. The current PA recommendations 
provide a good starting point for such a discussion. The accumulation of 150 minutes of 
moderate-intensity exercise per week, preferably spread throughout the week, might be 
sufficient to improve fitness, but at least 75 minutes of vigorous intensity exercise is also 
satisfactory if time is limited. Precise definitions of frequency, duration and intensity should 
be provided. Moreover, exercise prescription should be tailored to the individuals` 
characteristics by taking into account age and baseline CRF, preferably by prescribing 
exercise intensity on a relative scale and also by considering the accompanying risks of 
certain activities in high risk groups. 
Future research 
We recognize that the non-exercise models may need further refinement to be applicable for 
broad implementation in clinical practice. Firstly, it should be externally validated in a 
different cohort, preferably containing a larger number of high-risk subjects. Secondly, future 
studies should elucidate whether precision could be increased, without compromising 
simplicity, by further refinement of the PA variable and potentially including measures of 
self-rated CRF. Thirdly, longitudinal studies should also examine whether changes in 
estimated VO2peak are associated with different health outcomes. The HUNT database may be 
applicable for such a study if VO2peak could be estimated with the same model at minimum 
two time points (i.e. HUNT 1 and 2).  
 
The issue of dose-response between PA and VO2peak and their relation to different 
health outcomes also warrants further consideration. Paper II introduces a novel approach to 
estimate energy expenditure of exercise from the Borg scale in community-dwelling 
populations that could be used in prospective analysis of PA and future health. Planned 
follow-up studies of the HUNT Fitness Study population may also unveil how different 
exercise patterns and VO2peak interact as prognostic factors for cardiovascular and all-cause 
mortality as well as more rare outcomes such as specific types of cancers.  
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Conclusions 
The current thesis provides an internally well-validated prediction model that could estimate 
VO2peak reasonably well without exercise testing on the basis of age, an index of habitual PA, 
body composition and resting heart rate. Furthermore, we demonstrated that the non-exercise 
test could predict long-term cardiovascular and all-cause mortality, at least in men and women 
below 60 years at baseline. Notably, the relative risk reductions were similar to those reported 
by studies utilizing direct measurement of VO2peak. Lastly, we provide evidence that exercise 
patterns in accordance with current recommendations were associated with a beneficial 
VO2peak both among participants preferring a high amount at a moderate relative intensity and 
a lower amount at a vigorous intensity.  
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STEP 1 
 
PHYSICAL ACTIVITY INDEX 
 
Choose the option that best matches your usual exercise habits. Examples of exercise can be walking, skiing, 
cycling, swimming and indoor or outdoor sports. 
 
 
How often do you exercise? 
 
Never or less than once per week         
      
Once a week         
 
Two to three times a week       
 
Almost every day         
 
How hard do you usually push yourself?          * 
 
I take it easy without losing my breath or breaking into sweat  
 
I lose my breath and break into sweat     
 
Almost to exhaustion        
 
For how long do usually exercise?           * 
 
Less than 30 minutes per session      
 
More than 30 minutes per session     
               = 
Your physical activity index score:      1 → Add to STEP 2 
 
 
STEP 2 
 
Estimate cardiorespiratory fitness  MEN    WOMEN 
 
Constant              
         −          − 
Age in years      x 0.296       x 0.247   
   −         − 
Waist circumference (cm)    x 0.369       x 0.259 
   −   − 
Resting heart rate (beats per min)   x 0.155       x 0.114 
         +         + 
Physical activity score    x 0.226       x 0.198 
         =         = 
Estimated peak oxygen uptake: ml∙kg-1∙min-1 ml∙kg-1∙min-1 
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Du inviteres herved til å delta i den tredje store Helseundersøkelsen i Nord-
Trøndelag (HUNT 3). Ved å delta får du en enkel undersøkelse av din egen helse, 
og du gir samtidig et viktig bidrag til medisinsk forskning.
Hver deltaker er like viktig, enten du er ung eller gammel, frisk eller syk, er HUNT-
veteran eller møter for første gang. Tilsvarende undersøkelse er tidligere gjennom-
ført i 1984-86 (HUNT 1) og 1995-97 (HUNT 2 og Ung-HUNT).  For å kunne studere
årsaker til sykdom, er det viktig at også de som tidligere har deltatt møter fram. 
Vennligst fyll ut spørreskjemaet, og ta det med når du møter til undersøkelse.
Undersøkelsen tar vanligvis ca 1/2 time. Du vil få brev med resultater fra dine
prøver etter noen uker. Dersom noen av resultatene er utenom det normale, vil du
bli anbefalt undersøkelse hos fastlegen din.
Du kan lese mer om HUNT 3 i den vedlagte brosjyren eller på www.hunt.ntnu.no.
Har du spørsmål, kan du også ringe til HUNT forskningssenter, tlf 74075180.
Vel møtt til undersøkelsen!
Vennlig hilsen
Steinar Krokstad Jostein Holmen Stig A. Slørdahl
Førsteamanuensis Professor, daglig leder Professor, dekanus
Prosjektleder HUNT 3 HUNT forskningssenter Det medisinske fakultet, NTNU
Dersom det foreslåtte tidspunktet ikke passer for deg, behøver du ikke
bestille ny time. Du kan møte når det passer deg innenfor åpningstiden,
men det kan da bli noe ventetid. Du kan også møte i en annen kommune,
hvis det skulle passe bedre. Takk for at du deltar!
Åpningstida: 
Invitasjon til HUNT 3
Tid og sted for oppmøte
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Slik fyller du ut skjemaet
Rett GaltX
• Skjemaet vil bli lest maskinelt. 
• Det er derfor viktig at du krysser av riktig:
• Krysser du feil sted, retter du ved å fylle boksen slik:
• Skriv tydelige tall:  
• Bruk bare svart eller blå penn. Ikke bruk blyant eller tusj.
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HELSE OG DAGLIGLIV SYKDOMMER OG PLAGER
Hvordan er helsa di nå?1
Dårlig
Har du noen langvarig (minst 1 år)
sykdom, skade eller lidelse av fysisk
eller psykisk art som nedsetter dine
funksjoner i ditt daglige liv? 
Hvor mye vil du si at dine funksjoner er nedsatt? 
2
Ikke helt god God Svært god
Ja Nei
Har du i løpet av de siste 12 måneder vært hos:6
Ja Nei
Har du vært innlagt i sykehus
i løpet av de siste 12 måneder?
7 Ja Nei
Har du kroppslige smerter nå som
har vart mer enn 6 måneder?
3
Hvor sterke kroppslige smerter har du hatt i løpet
av de siste 4 uker?
4
Ja Nei
Er bevegelseshemmet..................
Har nedsatt syn .............................
Har nedsatt hørsel ........................
Hemmet pga. kroppslig sykdom.
Hemmet pga. psykisk sykdom.....
Hjerteinfarkt ...................................
Angina pectoris (hjertekrampe) ...
Hjertesvikt ......................................
Annen hjertesykdom.....................
Hjerneslag/hjerneblødning ..........
Nyresykdom...................................
Astma .............................................
Kronisk bronkitt, emfysem, KOLS
Diabetes (sukkersyke)....................
Psoriasis..........................................
Eksem på hendene .......................
Kreftsykdom...................................
Epilepsi...........................................
Leddgikt (reumatoid artritt) ..........
Bechterews sykdom ......................
Sarkoidose .....................................
Beinskjørhet (osteoporose) ..........
Fibromyalgi ....................................
Slitasjegikt (artrose) .......................
Psykiske plager som du
har søkt hjelp for ...........................
Fastlege/allmennlege .....................................
Annen legespesialist utenfor sykehus ...........
Konsultasjon uten innleggelse 
- ved psykiatrisk poliklinikk.........................
- ved annen poliklinikk i sykehus ...............
Kiropraktor .......................................................
Homøopat, akupunktør, soneterapeut, hånds-
pålegger eller annen alternativ behandler ...
Har du hatt noe anfall med pipende
eller tung pust de siste 12 måneder?
8 Ja Nei
Har du noen gang de siste 5 år
brukt medisiner for astma, kronisk
bronkitt, emfysem eller KOLS?
9
Ja Nei
Bruker du, eller har du brukt,
medisin mot høyt blodtrykk?
10 Ja Nei
Har du noen gang fått påvist for
høyt blodsukker?
12 Ja Nei
Har du, eller har du noen
gang hatt, noen av disse
sykdommene/plagene: 
(Sett ett kryss pr. linje)
11
Mode-
rate Sterke
Meget
sterkeIngen
Meget
svake Svake
I hvilken grad har din fysiske helse eller følelses-
messige problemer begrenset deg i din vanlige
sosiale omgang med familie eller venner i løpet av
de siste 4 uker?
5
Mye
Kunne ikke
ha sosial
omgang
Ikke i det
hele tatt En del Litt
Hvis ja:
Hvis ja: I hvilken situasjon første gang?
Hvis ja, hvor gammel
var du første gang?
Litt
nedsatt
Middels
nedsatt
Mye
nedsatt
Ja Nei
Eksempel:
Ved helseundersøkelse... Under sykdom .............
Under svangerskap ......... Annet ............................
HELSETJENESTER
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
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år 
gammel
år 
gammel
H
E
LS
E
U
N
D
E
R
SØ
K
E
LS
E
N
 I 
N
O
R
D
-T
R
Ø
N
D
E
LA
G
HuNT skjema spørreundersøkelse red  13-09-06  17:16  Side 1
2
SIDE
H
E
LS
E
U
N
D
E
R
SØ
K
E
LS
E
N
 I 
N
O
R
D
-T
R
Ø
N
D
E
LA
G
Lårhalsbrudd ..............................
Brudd i handledd/underarm ....
Brudd/sammenfall av ryggvirvler
Nakkesleng (whiplash)...............
Har du noen gang hatt: 13
Ja Nei
Hjerneslag eller hjerneblødning 
før 60 års alder...........................................
Hjerteinfarkt før 60-års alder ....................
Astma..........................................................
Allergi/høysnue/neseallergi......................
Kronisk bronkitt/emfysem/KOLS..............
Kreftsykdom ...............................................
Psykiske plager ..........................................
Beinskjørhet (osteoporose).......................
Nyresykdom (ikke nyresten, 
urinveisinfeksjon, urinlekkasje) .................
Diabetes (sukkersyke)................................
Har du foreldre, søsken eller barn som
har, eller har hatt, følgende sykdommer?
(Sett ett kryss pr. linje)
14
Ja Nei
Vet
ikke
Trygg og rolig?................................
Glad og optimistisk? ......................
Nervøs og urolig?...........................
Plaget av angst? .............................
Irritabel?...........................................
Nedfor/deprimert? .........................
Ensom? ............................................
Nei, jeg har aldri røykt .....................................................
Hvis du aldri har røykt, hopp til spørsmål 22.
Nei, jeg har sluttet å røyke..............................................
Ja, sigaretter av og til (fest/ferie, ikke daglig) ...............
Ja, sigarer/sigarillos/pipe av og til .................................
Ja, sigaretter daglig .........................................................
Ja, sigarer/sigarillos/pipe daglig ....................................
Har du de to siste uker følt deg:
(Sett ett kryss pr. linje)
16
LittNei
Svært
mye
En god
del
Har noen av dine besteforeldre,
dine foreldres søsken eller dine
søskenbarn fått diagnosen diabetes
(type 1 eller type 2)?
15
Ja Nei
Røykte noen av de voksne 
innendørs da du vokste opp?
18 Ja Nei
Røykte mora di da du vokste opp?19 Ja Nei
Røyker du selv? 20
Svar på dette hvis du nå røyker daglig 
eller tidligere har røykt daglig: 
Hvor mange sigaretter røyker
eller røykte du vanligvis daglig?
21
Har du noen gang i livet opplevd at
noen over lengre tid har forsøkt å
kue, fornedre eller ydmyke deg?
17 Ja Nei
sigaretter
pr. dag
Hvor gammel var du da du
begynte å røyke daglig?
Hvis du tidligere har røykt daglig,
hvor gammel var du da du sluttet?
Svar på dette hvis du røyker eller har røykt 
av og til, men ikke daglig: 
Hvor mange sigaretter røyker
eller røykte du vanligvis i måneden?
Hvor gammel var du da du 
begynte å røyke av og til?
Hvis du tidligere har røykt av og til,
hvor gammel var du da du sluttet?
Bruker du, eller har du brukt, snus?22
Hvor gammel var du da du
begynte med snus?
Hvor mange esker snus
bruker/brukte du pr. måned?
esker snus
pr. måned
A
21
B
Hvis ja:
Nei, aldri .......................... Ja, av og til...................
Ja, men jeg har sluttet.... Ja, daglig .....................
Hvis du aldri har brukt snus, hopp til spørsmål 23.
SKADER
HVORDAN FØLER DU DEG?
TOBAKK
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Hvis ja, hvor gammel
var du første gang?
Eksempel:
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
år 
gammel
sigaretter
pr. mnd
år 
gammel
år 
gammel
år 
gammel
HuNT skjema spørreundersøkelse red  13-09-06  17:16  Side 2
3
SIDE
H
E
LS
E
U
N
D
E
R
SØ
K
E
LS
E
N
 I 
N
O
R
D
-T
R
Ø
N
D
E
LA
G
Hvis du bruker eller har brukt både sigaretter og 
snus, hva begynte du med først?
Omtrent hvor ofte har du i løpet av de siste 12 
måneder drukket alkohol? (Regn ikke med lettøl)
28
Hvis ja:
Har du drukket så mye at
du har kjent deg sterkt
beruset (full)? 
Da du begynte å bruke snus, var det for å prøve 
å slutte å røyke eller for å redusere røykinga? 
Hvor ofte spiser du vanligvis disse matvarene?
(Sett ett kryss pr. linje)
23
2 ggr
el mer
pr. dag
1 gang
pr. 
dag
4-6
ganger
pr. uke
1-3
ganger
pr. uke
0-3
ganger
pr. mnd
Vann, farris o.l ...............
Helmelk (søt/sur)...........
Annen melk (søt/sur) ....
Brus/saft med sukker....
Brus/saft uten sukker....
Juice eller nektar ..........
Antall kopper
Koke-
kaffe
Hvor mange glass drikker du vanligvis av følgende?
1/2 liter = 3 glass (Sett ett kryss pr. linje)
25
Aldri ..................................................................................
Sjeldnere enn en gang i uka ..........................................
En gang i uka ...................................................................
2-3 ganger i uka...............................................................
Omtrent hver dag............................................................
4 gl.
eller mer
pr. dag
2-3
gl. pr.
dag
1 gl.
pr.
dag
1-6
gl. pr
uke
Sjelden
eller
aldri
Tran ..........................................................
Omega-3-kapsler ....................................
Vitamin- og/eller mineraltilskudd..........
Bruker du følgende kosttilskudd?
(Sett ett kryss for hvert kosttilskudd)
24
Nei
Av 
og til
Ja,
daglig
ALKOHOLBRUK
MOSJON/FYSISK AKTIVITET
Hvor ofte driver du mosjon? (Ta et gjennomsnitt)32
Tar det rolig uten å bli andpusten eller svett ..............
Tar det så hardt at jeg blir andpusten og svett...........
Tar meg nesten helt ut ..................................................
Dersom du driver slik mosjon, så ofte som en eller 
flere ganger i uka; hvor hardt mosjonerer du? 
(Ta et gjennomsnitt)
33
Hvor mange kopper kaffe/te drikker du pr. døgn?
(Sett 0 dersom du ikke drikker kaffe/te daglig)
26
Hvor mange kopper kaffe
drikker du om kvelden
(etter kl 18)?
27
Antall 
kopper
Annen
kaffe Te
Antall glass
Hvor mange glass øl, vin eller brennevin drikker
du vanligvis i løpet av 2 uker? (Regn ikke med lettøl)
(Sett 0 hvis du ikke drikker alkohol)
30
Vin
Brenne-
vin
Har du drukket alkohol i løpet av
de siste 4 uker?
29 Ja Nei
Med mosjon mener vi at du f.eks går tur, går på ski,
svømmer eller driver trening/idrett.
31
Hvor lenge holder du på hver gang? 
(Ta et gjennomsnitt)
34
Snus.................................. Sigaretter......................
Omtrent samtidig .......... Husker ikke...................
(innenfor 3 måneder)
Nei.............................................. Ja, for å 
Ja, for å slutte å røyke ........... redusere røykinga........
Frukt/bær......................
Grønnsaker...................
Sjokolade/smågodt .....
Kokte poteter...............
Pasta/ris ........................
Pølser/hamburgere......
Fet fisk .........................
(laks, ørret, sild, makrell,
uer som pålegg/middag)
4-7 ganger pr. uke........... Ca 1 gang pr. måned ..
2-3 ganger pr. uke........... Noen få ganger pr. år .
ca 1 gang pr. uke ............ Ingen ganger siste år ..
2-3 ganger pr. måned..... Aldri drukket alkohol...
Nei................................
Ja, 1-2 ganger .............
Ja, 3 ganger eller mer
Hvor ofte drikker du 5 glass eller mer av øl, vin
eller brennevin ved samme anledning?
Aldri.................................. Ukentlig ........................
Månedlig ......................... Daglig...........................
Mindre enn 15 minutter.. 30 minutter – 1 time....
15-29 minutter ................. Mer enn 1 time ............
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Har du vanligvis minst 30 minutter
fysisk aktivitet daglig på arbeid
og/eller i fritida?
35 Ja Nei
Omtrent hvor mange timer sitter
du i ro på en vanlig hverdag? 
(Regn med både jobb og fritid)
36
Antall 
timer
cm Husker ikke
For det meste stillesittende arbeid 
(f.eks skrivebordsarbeid, montering) ...............................
Arbeid som krever at du går mye 
(f.eks ekspeditørarbeid, lett industriarb.,undervisning) .
Arbeid hvor du går og løfter mye
(f.eks postbud, pleier, bygningsarbeid)...........................
Tungt kroppsarbeid (f.eks skogsarbeid, tungt
jordbruksarbeid, tungt bygningsarbeid) .........................
Hvis du er i lønnet eller ulønnet arbeid, hvordan vil
du beskrive arbeidet ditt? (Sett ett kryss)
37
Omtrent hva var din høyde da du var 18 år? 38
kg Husker ikke
Omtrent hva var din kroppsvekt da du var 18 år?39
Nei, for tung
Er du fornøyd med vekta di nå?40
Nei, for lettJa
Er din kroppsvekt minst 2 kg lavere nå
enn for 1 år siden?
42 Ja Nei
Ja, mange ganger
Har du forsøkt å slanke deg i løpet av de siste 10 år? 41
Ja, noen gangerNei
Vet ikke
Hva er grunnen til dette?
Sykdom/stressSlanking
Hvis ja:
Har det vært dødsfall i nær familie?
(barn, ektefelle/samboer, søsken eller
foreldre)
43
Har du vært i overhengende livsfare
pga. alvorlig ulykke, katastrofe,
voldssituasjon eller krig?
44
Har du hatt samlivsbrudd i ekteskap
eller i lengre samboerforhold?
45
46
47
Vokste du opp på gård med husdyr?52
Hvis du har svart ja på et eller flere av spm 43, 44
eller 45; i hvilken grad har du hatt reaksjoner på
dette de siste 7 dager?
Hvem vokste du opp sammen med? 
49 Døde noen av dine
foreldre da du var barn?
50 Vokste du opp med kjæledyr?
48
53
Svært fornøyd ...................
Meget fornøyd..................
Ganske fornøyd ................
Både/og ............................
Nokså misfornøyd.........
Meget misfornøyd ........
Svært misfornøyd..........
Når du tenker på barndommen/oppveksten din, 
vil du beskrive den som:
Ble dine foreldre skilt, eller
flyttet de fra hverandre, da
du var barn?
Hvor mye melk eller yoghurt drakk du vanligvis?51
2-3 gl.
pr. dag
Mer enn
3 glass
pr. dag
Sjelden/
aldri
1-6 gl.
pr. uke
1 glass
pr. dag
Når du tenker på hvordan du har det for tida, er du
stort sett fornøyd med tilværelsen eller er du stort
sett misfornøyd? (Sett ett kryss)
54
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ikke i det hele tatt........... I moderat grad.............
Litt..................................... I høy grad.....................
Mor ................................... Andre slektninger ........
Far..................................... Adoptivforeldre ...........
Stemor/stefar................... Foster-/pleieforeldre ...
Nei ............................
Ja, før jeg var 7 år....
Ja, da jeg var 7-18 år
Nei .............................
Ja, før jeg var 7 år ....
Ja, da jeg var 7-18 år
Nei ................................
Ja, katt.............................. Ja, hund........................
Ja, hest............................. Ja, annet levende dyr .
Svært god ........................ Vanskelig ......................
God .................................. Svært vanskelig............
Middels ............................
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Kjære HUNT-deltaker
Takk for at du møtte til Helseundersøkelsen. Vi vil også be deg om å fylle ut dette
spørreskjemaet. Noen av spørsmålene likner de som du har svart på før, men det er viktig
at du allikevel besvarer alt. Opplysningene blir brukt til forskning og forebyggende
helsearbeid. Forskere vil kun ha tilgang til avidentifiserte data, det vil si at opplysningene
ikke kan spores tilbake til en enkelt person.
Slik fyller du ut skjemaet
Skjemaet vil bli lest maskinelt.
Det er derfor viktig at du krysser av riktig:  Rett    Galt
Krysser du feil et sted, retter du ved å fylle boksen slik:
Bruk svart eller blå penn. Ikke bruk blyant eller tusj.
Dato for utfylling: . . dd.mm.åååå
 Mosjon/fysisk aktivitet
1. Under arbeid (lønnet eller ulønnet) eller vanlige daglige gjøremål-
Hvordan vil du beskrive aktivitetsnivået ditt?
Med mosjon mener vi at du f.eks går tur, går på ski, svømmer eller driver trening/idrett.
2. Hvor ofte driver du mosjon? (ta et gjennomsnitt):
For det meste stillesittende aktiviteter
Aktiviteter som krever at du går mye
Aktiviteter hvor du går og løfter mye
Tungt kroppsarbeid
Aldri
Sjeldnere enn en gang i uka
 En gang i uka
2-3 ganger i uka
Omtrent hver dag
1
40101
3. Hvor lenge holder du på hver gang? (ta et gjennomsnitt)
4. På en skala fra 6-20, hvor hard er aktivitetene du vanligvis utfører når du
mosjonerer/trener?
Mindre enn 15 minutter
15-29 minutter
30 minutter – 1 time
Mer enn 1 time
6
7     Meget, meget lett
8
9     Meget lett
10
11   Ganske lett
12
13   Litt anstrengende
14
15   Anstrengende
16
17   Meget anstrengende
18
19   Svært anstrengende
20
2
40101
Smerte
5. Har du kroppslige smerter nå?
Hvis nei, gå til spørsmål 8.
7. Vennligst sett kryss der du har smerte nå. Du kan krysse av flere steder.
3
Hode
H kjeve/
Bryst
Mage
Underliv/
H håndledd/
H kne
H ankel/fot
Nakke
H skulder/
Øvre del av
H albue/
Korsrygg
H Hofte/
H Lår
H legg
V skulder/
V albue/
V Hofte/
V Lår
V legg
V kjeve/
V håndledd/
V kne
V ankel/fot
 FORAN
Høyre Venstre
BAK
Venstre Høyre
hånd
underarm
ansikt ansikt
overarm
sete
ryggen
overarm
underarm
sete
bekken
hånd
Generell helse
8. Hvordan vil du stort sett vurdere din helsetilstand i løpet av den siste uka?
 Utmerket Meget god God Nokså god Dårlig Svært dårlig
Ja Nei
6. Vennligst sett ring rundt det tallet som best angir hvor sterke smerter du har
akkurat nå. Skriv tydelig ring rundt tallet:  6
0 1 2 3 4 5 6 7 8 9 10
Ingen smerter                                            Verst tenkelige
    smerter
40101
13. I løpet av den siste uka, i hvilken grad begrenset din fysiske helse eller 
 følelsesmessige problemer din vanlige sosiale omgang med familie eller
 venner?
Ikke i det Svært lite    En del Mye Kunne ikke ha
 hele tatt sosial omgang
14. I løpet av den siste uka, i hvilken grad har du vært plaget av følelsesmessige 
 problemer (som f. eks. å være engstelig, deprimert eller irritabel)?
Ikke i det hele tatt  Litt   En del  Mye   Svært mye 
 
15. I løpet av den siste uka, i hvilken grad hindret personlige eller følelsesmessige 
 problemer deg fra å utføre ditt vanlige arbeid, skolegang eller andre gjøremål?
Ikke i det Svært lite    En del Mye Kunne ikke utføre
 hele tatt  daglige gjøremål
Vi vil gjerne vite når du fylte ut skjemaet i forhold til kondisjonstesten.
Var det:
9. I løpet av den siste uka, i hvilken grad begrenset fysiske helseproblemer dine 
vanlige fysiske aktiviteter (spasere, gå opp trapper)?
Ikke i det Svært lite En del  Mye    Kunne ikke
hele tatt    utføre fysiske 
   aktiviteter 
10. I løpet av den siste uka, hvor vanskelig var det for deg å utføre ditt vanlige
 arbeid (både i og utenfor hjemmet) på grunn av din fysiske helse?
Ikke i det Litt Nokså  Meget   Kunne ikke
hele tatt         utføre daglig
      arbeid 
11. Hvor sterke kroppslige smerter har du hatt i løpet av den siste uka?
     
Ingen Meget svake Svake Moderate Sterke Meget sterke
12. I løpet av den siste uka, hvor mye overskudd hadde du?
Svært mye Ganske mye En del Litt Ikke noe
    
Før Etter Både før og etter
4
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Kondisprosjektet
 Dag i MS-syklus:
   
   Kommentar:
Blodtrykk:   Vekt:    kg Høyde: cm
    systolisk      diastolisk
Diabetes     type Midjemål:  cm
Find-risk Medisiner:  hvilke?
Spørsmål fra lege
Pipende eller tung pust siste 12 mnd, astma, kronisk bronkitt,
KOLS eller sarkoidose, hjertesykdom, angina eller medisin mot
høyt blodtrykk, hjerneslag/-blødning, kreftsykdom, gravid, blind:...
Medisinsk kontraindikasjon mot fysisk aktivitet:....................................
Klarer du gå i motbakke eller trapper:........................................................
Info (for legen):
Fysisk arbeid og fysisk aktivitet
"Hvor mange av de siste 7 dagene har du utført fysisk arbeide eller
fysisk aktivitet som varte minst 10 minutter sammenhengende?" dager
"Hvor lenge holdt du gjennomsnittlig på med slike aktiviteter
på de dagene du har nevnt?/Hvor lenge holdt du på med   timer       min
slike aktiviteter denne dagen?"
"Jeg skal nå spørre deg om hvor hardt du har tatt i under aktiviteten eller arbeidet de siste 7 dagene. I
den sammenheng har vi delt inn aktiviteten i følgende tidsintervaller: (1) 61 minutter eller mer, (2) 31-60
minutter, (3) 10-30 minutter." La gjennomsnittet bestemme hvilken varighet du spør om først. "For å
beskrive intensiteten bruker vi Borg skala som du ser her. (Intervjuer peker på Borg skala). Du kan velge
alle tallene. Da spør jeg: Hvor hardt tok du i under aktiviteten/arbeidet ...?" Spør om alle
tidsintervallene.
10-30 minutter 31-60 minutter 61 minutter eller mer
Hvilket tidsintervall har du tilbrakt mest tid i den siste uka?
Dato: . .
Personnummmer: -
Mann Kvinne
Hormoner: Ja Nei
Kode:
/ . .
Nei Ja, eksl.
Nei Ja, eksl.
Ja Nei, eksl.
Menopause: Før Under Etter
Nei Ja,
10-30 31-60 61 eller mer
P-piller/spiral: Ja Nei
1 2
Nei Ja,
.
30488
Kondisprosjektet
Endotelfunksjon
Stimulans i dag:   Forrige:    timer    min
    Kaffe:         timer      min
Forrige næringsinntak (alt unntatt vann):     timer      min
Har du trent i dag?          timer      min
Medisiner i dag?
Faste medisiner?
Baseline: Post:
   flow   diameter laveste puls flow(10 sek)   diameter(1 min)
  
Oksygenopptak
km/t  % stigning      hjertefrekvens    VO2 (L/min)     Borg
   Startbelastning:
               Trinn 2:
  VO2max / VO2peak:
  RER  ventilasjon
Tilbakemelding: VO2max:_________ mL/kg/min Makspuls:_________ slag/min
Kommentar endotel eller VO2:
Ikke gjennomført:
. .
.
.
.
.
.
.
.
Kondis Endotel Spørreskjema
Nei Røyketobakk Snus/skrå Alkohol
Nei Ja, for
Nei Ja, for
Nei Ja, hvilke?
Nei Ja, hvilke?
Kode:
30488







